Section 9

EurekaMag PDF full texts Chapter 8,312


Mcconnell, L., L.; Nelson, E.; Rice, C., P.; Baker, J., E.; Johnson, W.E.ward; Harman, J., A.; Bialek, K. 1997: Chlorpyrifos in the air and surface water of Chesapeake Bay: Predictions of atmospheric deposition fluxes. Environmental Science and Technology 31(5): 1390-1398
Huff, R.A.; Corcoran, J.J.; Anderson, J.K.; Abou-Donia, M.B. 1994: Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. Journal of Pharmacology and Experimental Therapeutics 269(1): 329-335
Cohn, J.; MacPhail, R.C. 1997: Chlorpyrifos produces selective learning deficits in rats working under a schedule of repeated acquisition and performance. Journal of Pharmacology and Experimental Therapeutics 283(1): 312-320
Yoshida, S. 1994: Chlorpyrifos residues in air and polished rice stock in a house treated for termite control. Journal of the Food Hygienic Society of Japan 35(3): 287-291
Lino, C.M.; da Silveira, M.I. 1994: Chlorpyrifos, ethion, fenitrothion, and methidathion residues in chickens. Bulletin of Environmental Contamination and Toxicology 52(3): 425-431
Katz, E.J.; Cortes, V.I.; Eldefrawi, M.E.; Eldefrawi, A.T. 1997: Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Toxicology and Applied Pharmacology 146(2): 227-236
Cochran, R.C.; Kishiyama, J.; Aldous, C.; Carr, W.C.; Pfeifer, K.F. 1995: Chlorpyrifos: hazard assessment based on a review of the effects of short-term and long-term exposure in animals and humans. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 33(2): 165-172
Maxwell, W.M.; Johnson, L.A. 1997: Chlortetracycline analysis of boar spermatozoa after incubation, flow cytometric sorting, cooling, or cryopreservation. Molecular Reproduction and Development 46(3): 408-418
Dvorak, M.; Miller, V.; Hlavizna, L.-Vv-Janeckovaan; Benuska, M.-Norbert 1993: Chlortetracycline residues in pigs after oral application of the chlortetracycline feed grade preparation (Biotika). Biopharm 3(3-4): 91-102
Bradley, K.; Flack, J.M.; Belcher, J.; Elmer, P.; Miller, P.; Grimm, R. 1993: Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss. American Journal of Hypertension 6(7 Part 1): 636-639
Bissoli, N.S.; Vasquez, E.C.; Cabral, A.M. 1996: Chlorthalidone-modulated vascular responses to vasodilator stimuli in DOCA-salt hypertensive rats. Pharmacological Research 33(1): 47-54
Chueca, M.C.; Sixto, H.; Matienzo, M.T.; Tadeo, J.L.; Garcia Baudin, J.M. 1994: Chlortoluron selectivity in Triticum durum L. Investigacion Agraria Produccion y Proteccion Vegetales 1994(Suppl 2): 153-160
Amato, G.; Longo, V.; Mazzaccaro, A.; Gervasi, P.G. 1998: Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver. Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(5): 483-489
Bachmann, K.; Sarver, J.G. 1996: Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans. Pharmacology 52(3): 169-177
Anonymous 1996: Chlorzoxazone hepatotoxicity. Medical Letter on Drugs and Therapeutics 38(974): 46
Ono, S.; Hatanaka, T.; Hotta, H.; Tsutsui, M.; Satoh, T.; Gonzalez, F.J. 1995: Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5(3): 143-150
Wall, K.L.; Crivello, J. 1998: Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts. Toxicology and Applied Pharmacology 151(1): 98-104
Hayashi, M.; Kim, Y.P.; Takamatsu, S.; Preeprame, S.; Komiya, T.; Masuma, R.; Tanaka, H.; Komiyama, K.; Omura, S. 1996: Chlovalicin, a new cytocidal antibiotic produced by Sporothrix sp. FO-4649. I. Taxonomy, fermentation, isolation and biological activities. Journal of Antibiotics 49(7): 631-634
Takamatsu, S.; Kim, Y.P.; Komiya, T.; Sunazuka, T.; Hayashi, M.; Tanaka, H.; Komiyama, K.; Omura, S. 1996: Chlovalicin, a new cytocidal antibiotic produced by Sporothrix sp. FO-4649. II. Physicochemical properties and structural elucidation. Journal of Antibiotics 49(7): 635-638
Wilson, L.C.; Kerr, B.A.; Wilkinson, R.; Fossard, C.; Donnai, D. 1998: Choanal atresia and hypothelia following methimazole exposure in utero: A second report. American Journal of Medical Genetics 75(2): 220-222
Eloy, P.; Evrard, I.; Bertrand, B.; Delos, M. 1996: Choanal polyp of sphenoidal origin. Report of two cases. Acta Oto-Rhino-Laryngologica Belgica 50(3): 183-189
Lopatin, A.; Bykova, V.; Piskunov, G. 1997: Choanal polyps: one entity, one surgical approach?. Rhinology 35(2): 79-83
Lopatin, A.S.; Bykova, V.P.; Artsybasheva, M.V. 1997: Choanal polyps: principles of current diagnosis and treatment. Vestnik Otorinolaringologii 1997(1): 8-12
Teri, J.M.; Mlasani, D.K. 1994: Choanephora blight and alternaria leaf spot of Amaranth in Tanzania. Plant Pathology 43(1): 228-229
Hara, S.; Chen, Y.-Ling, L.; Sheu, J.-Chi; Takahashi, E. 1996: Choanoflagellates (Sarcomastigophora, Protozoa) from the coastal waters of Taiwan and Japan. I. Three new species. Journal of Eukaryotic Microbiology 43(2): 136-143
Tong, S.M. 1997: Choanoflagellates in Southampton Water, including the description of three new species. Journal of the Marine Biological Association of the United Kingdom 77(4): 929-958
Joo, S.-Jae; Kies, C.; Schnepf, M. 1995: Chocolate and chocolate-like products: Impact on copper status of humans. Journal of Applied Nutrition 47(3): 67-77
Kris-Etherton, P.M.; Mustad, V.A. 1994: Chocolate feeding studies: a novel approach for evaluating the plasma lipid effects of stearic acid. American Journal of Clinical Nutrition 60(6 Suppl): 1029s-1036s
Jovanovic, O.; Karlovic, D.; Jakovijevic, J. 1995: Chocolate pre-crystallization: A review. Acta Alimentaria 24(3): 225-239
Morgan, J. 1994: Chocolate: a flavor and texture unlike any other. American Journal of Clinical Nutrition 60(6 Suppl): 1065s-1067s
Singh, B.N. 1993: Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy. American Journal of Cardiology 72(16): 114F-124F
Omino, T.; Ito, M. 1993: Choice and delay of reinforcement: Effects of terminal-link stimulus and response conditions. Journal of the Experimental Analysis of Behavior 59(2): 361-371
Mazur, J.E. 1992: Choice behavior in transition: development of preference with ratio and interval schedules. Journal of Experimental Psychology. Animal Behavior Processes 18(4): 364-378
Woolverton, W.L.; English, J.A.; Weed, M.R. 1997: Choice between cocaine and food in a discrete-trials procedure in monkeys: A unit price analysis. Psychopharmacology 133(3): 269-274
Ho, M.Y.; Wogar, M.A.; Bradshaw, C.M.; Szabadi, E. 1997: Choice between delayed reinforcers: Interaction between delay and deprivation level. Quarterly Journal of Experimental Psychology Section B Comparative and Physiological Psychology 50(3): 193-202
Grace, R.C. 1996: Choice between fixed and variable delays to reinforcement in the adjusting-delay procedure and concurrent chains. Journal of Experimental Psychology Animal Behavior Processes 22(3): 362-383
Brunner, D.; Gibbon, J.; Fairhurst, S. 1994: Choice between fixed and variable delays with different reward amounts. Journal of Experimental Psychology. Animal Behavior Processes 20(4): 331-346
Mikheev, V.N. 1995: Choice between individual and group behavior in fishes with an optional social strategy. Voprosy Ichtiologii 35(4): 515-518
Belke, T.W.; Spetch, M.L. 1994: Choice between reliable and unreliable reinforcement alternatives revisited: Preference for unreliable reinforcement. Journal of the Experimental Analysis of Behavior 62(3): 353-366
Davison, M. 1992: Choice between repleting/depleting patches: A concurrent-schedule procedure. Journal of the Experimental Analysis of Behavior 58(3): 445-469
Suzuki, S.; Matsuzawa, T. 1997: Choice between two discrimination tasks in chimpanzees (Pan troglodytes). Japanese Psychological Research 39(3): 226-235
Brown, M., F.; Lesniak-Karpiak, K., B. 1993: Choice criterion effects in the radial arm maze: Maze-arm incline and brightness. Learning and Motivation 24(1): 23-39
Glover, D., A.; Hanley, G., L. 1993: Choice in a multi-response environment: Testing response substitution for an inelastic behavior. Learning and Motivation 24(4): 433-457
Tobin, H.; Chelonis, J.J.; Logue, A.W. 1993: Choice in self-control paradigms using rats. Psychological Record 43(3): 441-453
Preston, R.A. 1994: Choice in the time-left procedure and in concurrent chains with a time-left terminal link. Journal of the Experimental Analysis of Behavior 61(3): 349-373
Woolverton, W.L.; Rowlett, J.K. 1998: Choice maintained by cocaine or food in monkeys: Effects of varying probability of reinforcement. Psychopharmacology 138(1): 102-106
Stahl, N.; Farruggella, T.J.; Boulton, T.G.; Zhong, Z.; Darnell, J.E.; Yancopoulos, G.D. 1995: Choice of STATs and Other Substrates Specified by Modular Tyrosine-Based Motifs in Cytokine Receptors. Science 267(5202): 1349-1353
Guzev, K.S.; Gretskii, V.M.; Kon', I.Y.; Yakushkina, L.M. 1992: Choice of a carrier for suppositories containing 13-cis-retinoic acid. Farmatsiya 41(5): 25-29
Abramov, S.S. 1996: Choice of a method of investigation in forensic medical osteological identification. Sudebno-Meditsinskaya Ekspertiza 38(4): 13-20
Wallet, F.; Roussel-Delvallez, M.; Courcol, R.J. 1996: Choice of a routine method for detecting methicillin-resistance in staphylococci. Journal of Antimicrobial ChemoTherapy 37(5): 901-909
Xu, Z.M.; De Vel, E.; Vinck, B.; van Cauwenberge, P.B. 1997: Choice of a tone-pip envelope for frequency-specific threshold evaluations by means of the middle-latency response: Normally hearing subjects and slope of sensorineural hearing loss. Auris Nasus Larynx 24(4): 333-340
Caudron, I.; Grulke, S.; Miesen, M.; Benbarek, H.; Serteyn, D. 1996: Choice of a treatment for nephrosplenic entrapment of the large colon in horses: Laparotomy or non-surgical correction. Annales de Medecine Veterinaire 140(5): 357-358, 360-362
Zalewski, A. 1996: Choice of age classes of bank vole Clethrionomys glareolus by pine marten Martes martes and tawny owl Strix aluco in Bialowieza National Park. Acta Oecologica 17(3): 233-244
Goldstein, F.W. 1997: Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae. Scandinavian Journal of Infectious Diseases 29(3): 255-257
Guest, C.B.; Byrick, R.J.; Mazer, C.D.; Wigglesworth, D.F.; Mullen, J.B.; Tong, J.H. 1995: Choice of anaesthetic regimen influences haemodynamic response to cemented arthroplasty. Canadian Journal of Anaesthesia 42(10): 928-936
Svetlov, V.A.; Kozlov, S.P.; Shatrov, A.I. 1995: Choice of anesthesia in geriatric patients operated on the lower limbs. Anesteziologiya i Reanimatologiya 1995(2): 53-56
Chung, S.J.; Gosnell, W.O.; Purkey, M.S. 1995: Choice of antibiotics by the site of infection in a community hospital. International Journal of Bio-Medical Computing 40(1): 31-39
Kruse, H.; Hofshagen, M.; Thoresen, S.I.; Vollset, W.P. V.B.; Soli, N.E. 1996: Choice of antibiotics in treating canine dermatitis. Norsk Veterinaertidsskrift 108(5): 307-312
Isacsson, G.; Redfors, I.; Wasserman, D.; Bergman, U. 1994: Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden. BMJ 309(6968): 1546-1549
Davis, G.L.; Lau, J.Y. 1995: Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection. Journal of Hepatology 22(1 Suppl): 110-114
Herrmann, E.; Gasser, T.; Kneip, A. 1992: Choice of bandwidth for kernel regression when residuals are correlated. Biometrika 79(4): 783-795
Hilhorst, M.J.; Somsen, G.W.; de Jong, G.J. 1998: Choice of capillary electrophoresis systems for the impurity profiling of drugs. Journal of Pharmaceutical and Biomedical Analysis 16(7): 1251-1260
Schall, R.; Luus, H.G.; Steinijans, V.W.; Hauschke, D. 1994: Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations. International Journal of Clinical Pharmacology and Therapeutics 32(7): 323-328
Skjeldestad, F.E. 1994: Choice of contraceptive modality by women in Norway. Acta Obstetricia et Gynecologica Scandinavica 73(1): 48-52
Nadazdin, M.; Koljajic, V.; Rajic, I.; Radivojevic, R.; Jakobcic, Z. 1995: Choice of corn hybrids from the aspect of utilization in diet of poultry and pigs. Veterinarski Glasnik 49(7-8): 449-456
Koltukova, N.V.; Mendzhul, M.I.; Zabolotnaya, G.M.; Koshel, M.I. 1995: Choice of cyanobacteria cultures for tertiary treatment of sewage of alcohol-yeast production. Mikrobiolohichnyi Zhurnal 57(3): 78-83
Bresnahan, P., A.; Miller, D., R. 1997: Choice of data scale: Predicting resolution error in a regional evapotranspiration model. Agricultural and Forest Meteorology 84(1-2): 97-113
Plowright, C.; Cantin-Plante, N. 1997: Choice of direction of flight paths between flowers by foraging bumble bees (Bombus). Canadian Entomologist 129(5): 915-925
Larsen, F.; Gundersen, G.; Prydz, H. 1992: Choice of enzymes for mapping based on CpG Islands in the human genome. Genetic Analysis Techniques and Applications 9(3): 80-85
Chernousov, A.F.; Andrianov, V.A.; Bogopol'skii, P.M.; Voronov, M.E. 1997: Choice of esophageoplastic method. Vestnik Rossitskol Akademii Meditsinskikh nauk 1997(9): 21-25
Ffrench, M.; Morel, F.; Souchier, C.; Benchaib, M.; Catallo, R.; Bryon, P.A. 1994: Choice of fixation and denaturation for the triple labelling of intra-cytoplasmic antigen, bromodeoxyuridine and DNA. Application to bone marrow plasma cells. Histochemistry 101(5): 385-390
Estabrook, G.F. 1994: Choice of fuel for bagaco stills helps maintain biological diversity in a traditional Portuguese agricultural system. Journal of Ethnobiology 14(1): 43-57
Parker, M.J.; Blundell, C. 1998: Choice of implant for internal fixation of femoral neck fractures. Meta-analysis of 25 randomised trials including 4,925 patients. Acta Orthopaedica Scandinavica 69(2): 138-143
Anonymous 1996: Choice of lipid-lowering drugs. Medical Letter on Drugs and Therapeutics 38(980): 67-70
Heudebert, G.R.; Marks, R.; Wilcox, C.M.; Centor, R.M. 1997: Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysis. Gastroenterology 112(4): 1078-1086
Runge, V.M.; Wells, J.W. 1996: Choice of metal ion and formulation concentration for first-pass brain perfusion studies with magnetic resonance imaging at 1.5 tesla. Investigative Radiology 31(7): 395-400
Yudin, Y.B.; Adamenko, O.B. 1994: Choice of method of urine derivation in bladder extrophy in children. Urologiya i Nefrologiya 1994(6): 15-17
Wilkinson, D.; Ward, J.M.; Woodley, J.M. 1996: Choice of microbial host for the naphthalene dioxygenase bioconversion. Journal of Industrial Microbiology 16(5): 274-279
Mouritsen, K.N.; Jensen, K.T. 1992: Choice of microhabitat in tactile foraging dunlins Calidris alpina: The importance of sediment penetrability. Marine Ecology Progress Series 85(1-2): 1-8
Podgorskii, V.S.; Shvets, V.N.; Grek, E.V.; Ivanova, L.A.; Todosiichuk, S.R.; Gavrilenko, M.N.; Nagornaya, S.S.; Dvornik, S.A. 1996: Choice of microorganisms efficiently fermenting the whey lactose. Mikrobiolohichnyi Zhurnal 58(4): 24-28
Hoskins, P.R. 1994: Choice of moving target for a string phantom: I. Measurement of filament backscatter characteristics. Ultrasound in Medicine and Biology 20(8): 773-780
Hoskins, P.R. 1994: Choice of moving target for a string phantom: II. On the performance testing of Doppler ultrasound systems. Ultrasound in Medicine and Biology 20(8): 781-789
Carlier, P. 1993: Choice of nest site by the peregrine falcon Falco peregrinus brookei in the Sierras Subbeticas Cordobesas Natural Park. Alauda 61(2): 111-117
Cantore, G.; Ciappetta, P.; Delfini, R. 1994: Choice of neurosurgical approach in the treatment of cranial base lesions. Neurosurgical Review 17(2): 109-125
Hinson, R.A.; Turner, S.C. 1994: Choice of nursery-appropriate marketing channels in the landscape plant industry. Journal of Environmental Horticulture 12(2): 76-79
Ozkardeş, H. 1994: Choice of open surgery for varicocele. International Urology and Nephrology 26(2): 193-197
Holt, C.; Holt, W.V.; Moore, H.D. 1996: Choice of operating conditions to minimize sperm subpopulation sampling bias in the assessment of boar semen by computer-assisted semen analysis. Journal of Andrology 17(5): 587-596
Hughes, R.E. 1995: Choice of optimization models for predicting spinal forces in a three-dimensional analysis of heavy work. Ergonomics 38(12): 2476-2484
Urushihara, H. 1996: Choice of partners: sexual cell interactions in Dictyostelium discoideum. Cell Structure and Function 21(4): 231-236
Goldman, J.M.; Szydlo, R.; Horowitz, M.M.; Gale, R.P.; Ash, R.C.; Atkinson, K.; Dicke, K.A.; Gluckman, E.; Herzig, R.H.; Marmont, A. 1993: Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 82(7): 2235-2238
Harvey, J.C.; Pisch, J.; Rubin, E.; Beattie, E.J. 1993: Choice of procedure for surgical treatment of non-small cell lung cancer. Seminars in Surgical Oncology 9(2): 92-98
Meia, J.S.; Weber, J.M. 1993: Choice of resting sites by female foxes Vulpes vulpes in a mountainous habitat. Acta Theriologica 38(1): 81-91
Vintzileos, A.M.; Guzman, E.R.; Smulian, J.C.; McLean, D.A.; Ananth, C.V. 1997: Choice of second-trimester genetic sonogram for detection of trisomy 21. Obstetrics and Gynecology 90(2): 187-190
Schjetlein, R.; Wisløff, F. 1993: Choice of standard plasma for diagnosis and quantitation of lupus anticoagulants. Thrombosis Research 72(4): 287-294
Penta, J.S.; Rosner, G.L.; Trump, D.L. 1992: Choice of starting dose and escalation for phase I studies of antitumor agents. Cancer Chemotherapy and Pharmacology 31(3): 247-250
Trishkin, V.A.; Stolyarov, V.I. 1991: Choice of the extent of surgical intervention in patients with soft tissue tumors of the torso. Voprosy Onkologii (St Petersburg) 37(9-10): 959-961
Yarovaya, E.V.; Rostapshova, T.V.; Susekov, A.V.; Kukharchuk, V.V. 1993: Choice of the optimum regimen of low density lipoprotein apheresis in patients with familial hypercholesterolemia using mathematical modelling. Kardiologiya 33(10): 6, 50-54
Zuppi, C.; Baroni, S.; Scribano, D.; Di Salvo, S.; Musumeci, V. 1995: Choice of time for urine collection for detecting early kidney abnormalities in hypertensives. Annals of Clinical Biochemistry 32: 373-378
Van Winsum, W.; Heino, A. 1996: Choice of time-headway in car-following and the role of time-to-collision information in braking. Ergonomics 39(4): 579-592
Lydersen, T. 1997: Choice of timeout from fixed-time schedules: Comparison of two procedures. Behavioural Processes 40(2): 137-147
Gibson, J.M.; Westwood, M.; Crosby, S.R.; Gordon, C.; Holly, J.M.; Fraser, W.; Anderson, C.; White, A.; Young, R.J. 1995: Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 80(4): 1369-1375
Lopatkin, N.A.; Igel'nik, A.M.; Popovkin, N.N.; Orlova, E.V. 1994: Choice of treatment for presenile and senile patients with renal carcinoma. Urologiya i Nefrologiya 1994(4): 22-24
Szabo, E.; Moody, H.; Hamilton, T.; Ang, C.; Kovithavongs, C.; Kjellstrand, C. 1997: Choice of treatment improves quality of life. A study on patients undergoing dialysis. Archives of Internal Medicine 157(12): 1352-1356
Pal'chun, V.T.; Kadymova, M.I. 1994: Choice of treatment in Meniere's disease and similar disorders. Vestnik Otorinolaringologii 1994(2): 5-9
Nakano, K.; Kobayashi, J.; Sasako, Y.; Yamamoto, F.; Kosakai, Y. 1998: Choice of valve substitute in elderly patients and late results after valve replacement. Japanese Journal of Artificial Organs 27(1): 183-186
Luce, M.F.; Bettman, J.R.; Payne, J.W. 1997: Choice processing in emotionally difficult decisions. Journal of Experimental Psychology. Learning Memory and Cognition 23(2): 384-405
Reed, T.E.; Jensen, A., R. 1993: Choice reaction time and visual pathway nerve conduction velocity both correlate with intelligence but appear not to correlate with each other: Implications for information processing. Intelligence 17(2): 191-203
Chmura, J.; Nazar, K.; Kaciuba-Uściłko, H. 1994: Choice reaction time during graded exercise in relation to blood lactate and plasma catecholamine thresholds. International Journal of Sports Medicine 15(4): 172-176
Mazur, J.E. 1996: Choice with certain and uncertain reinforcers in an adjusting-delay procedure. Journal of the Experimental Analysis of Behavior 66(1): 63-73
Mazur, J.E.; Romano, A. 1992: Choice with delayed and probabilistic reinforcers: effects of variability, time between trials, and conditioned reinforcers. Journal of the Experimental Analysis of Behavior 58(3): 513-525
Mazur, J.E. 1997: Choice, delay, probability, and conditioned reinforcement. Animal Learning and Behavior 25(2): 131-147
Noishiki, Y.; Yamane, Y.; Okoshi, T.; Tomizawa, Y.; Satoh, S. 1998: Choice, isolation, and preparation of cells for bioartificial vascular grafts. Artificial Organs 22(1): 50-62
Stephenson, J.; Linfoot, K. 1995: Choice-making as a natural context for teaching early communication board use to a ten year old boy with no spoken language and severe intellectual disability. Australia and New Zealand Journal of Developmental Disabilities 20(4): 263-286
Zimmerman, M.; Brody, A.K. 1998: Choices and consequences of oviposition by Hylemya (Delia) sp. (Diptera: Anthomyiidae). Journal of Insect Behavior 11(3): 371-381
Tan, W.C.; Chia, K.S.; Goh, L.G. 1992: Choices and preferences in asthma management. Singapore Medical Journal 33(6): 590-594
Koene, R.A.; Hilbrands, L.B. 1998: Choices of long-term immunosuppression in renal transplantation: balancing the benefits and risks. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 13(4): 844-846
Waye, H.L.; Gregory, P.T. 1993: Choices of neonate Thamnophis elegans vagrans between conspecific, congeneric, and heterogeneric odors. Journal of Herpetology 27(4): 435-441
Mcnally, R.J. 1994: Choking phobia: A review of the literature. Comprehensive Psychiatry 35(1): 83-89
Choi, P.M.; Nugent, F.W.; Zelig, M.P.; Munson, J.L.; Schoetz, D.J. 1994: Cholangiocarcinoma and Crohn's disease. Digestive Diseases and Sciences 39(3): 667-670
Hasebe, T.; Sakamoto, M.; Mukai, K.; Kawano, N.; Konishi, M.; Ryu, M.; Fukamachi, S.; Hirohashi, S. 1995: Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma. Virchows Archiv: An International Journal of Pathology 426(2): 209-213
Wadhwa, D.R.; Rao, V.N.; Prasad, B.; Dhaliwal, A.S. 1996: Cholangiocarcinoma in dog: A case report. Indian Veterinary Journal 73(3): 315-317
Alden, M.E.; Waterman, F.M.; Topham, A.K.; Barbot, D.J.; Shapiro, M.J.; Mohiuddin, M. 1995: Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct. Radiology 197(2): 511-516
Lacomis, J.M.; Baron, R.L.; Oliver, J.H.; Nalesnik, M.A.; Federle, M.P. 1997: Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203(1): 98-104
Garber, S.J.; Donald, J.J.; Lees, W.R. 1993: Cholangiocarcinoma: Ultrasound features and correlation of tumor position with survival. Abdominal Imaging 18(1): 66-69
Sasaki, M.; Nakanuma, Y.; Ho, S.B.; Kim, Y.S. 1998: Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. American Journal of Clinical Pathology 109(3): 302-308
Iyomasa, S.; Nimura, Y.; Kamiya, J.; Maeda, S.; Kondo, S.; Yasui, A.; Yamamoto, H.; Anami, Y.; Shionoya, S.; Takayama, T. 1992: Cholangiocellular carcinoma in the caudate lobe with intraluminal growth in the extrahepatic bile duct. Hepato-Gastroenterology 39(6): 570-573
Roberts, S.K.; Yano, M.; Ueno, Y.; Pham, L.; Alpini, G.; Agre, P.; LaRusso, N.F. 1994: Cholangiocytes express the aquaporin CHIP and transport water via a channel-mediated mechanism. Proceedings of the National Academy of Sciences of the United States of America 91(26): 13009-13013
Altman, C.; Fabre, M.; Adrien, C.; Frouge, C.; Fritsch, J.; Martin, E.; Bléry, M.; Etienne, J.P. 1995: Cholangiographic features in fibrosis and cirrhosis of the liver. Radiological-pathological correlation. Digestive Diseases and Sciences 40(10): 2128-2133
Reuther, G.; Kiefer, B.; Tuchmann, A. 1996: Cholangiography before biliary surgery: single-shot MR cholangiography versus intravenous cholangiography. Radiology 198(2): 561-566
Wu, C.S.; Wu, S.S.; Chen, P.C.; Chiu, C.T.; Lin, S.M.; Jan, Y.Y.; Hung, C.F. 1994: Cholangiography of icteric type hepatoma. American Journal of Gastroenterology 89(5): 774-777
Cerny, E.; Bucek, J.; Papousek, F. 1996: Cholangiohepatitis in liver tissue adherent to gallbladder wall. Scripta Medica 69(1-2): 39-43
Le Thi Huong, D.; Valla, D.; Franco, D.; Wechsler, B.; De Gramont, A.; Auperin, A.; Godeau, P. 1995: Cholangitis Associated With Paroxysmal Nocturnal Hemoglobinuria: Another Instance of Ischemic Cholangiopathy?. Gastroenterology 109(4): 1338-1343
Nomura, T.; Shirai, Y.; Hatakeyama, K. 1997: Cholangitis after endoscopic biliary drainage for hilar lesions. Hepato-Gastroenterology 44(17): 1267-1270
Burgart, L.J. 1998: Cholangitis in viral disease. Mayo Clinic Proceedings 73(5): 479-482
Campanella, L.; Battilotti, M.; Borraccino, A.; Colapicchioni, C.; Sammartino, M.P.; Tomassetti, M. 1993: Cholanic acids determined in commercial drugs by means of a new ISFET device. Journal of Pharmaceutical and Biomedical Analysis 11(11-12): 1207-1214
Bester, M.J.; Potgieter, H.C.; Vermaak, W.J. 1994: Cholate and pH reduce interference by sodium dodecyl sulfate in the determination of DNA with Hoechst. Analytical Biochemistry 223(2): 299-305
Mynatt, R.L.; Greenhaw, J.J.; Cook, G.A. 1994: Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-i by a mechanism involving phospholipids. Biochemical Journal 299: 761-767
Ariën, A.; Toulmé-Henry, N.; Dupuy, B. 1995: Cholate-induced disruption of calcitonin-loaded liposomes: Formation of trypsin-resistant lipid-calcitonin-cholate complexes. Pharmaceutical Research 12(9): 1289-1292
Viguerie, Y.; Kammerer, M.; Kane, Y.; Harry, P.; Tourmen, Y. 1995: Cholecalciferol acute intoxication: Experimental therapeutic assay in rabbit. Recueil de Medecine Veterinaire de l'Ecole d'Alfort 171(6-7): 431-439
Mattila, P.; Piironen, V.; Lehikoinen, K.; Backman, C.; Uusi Rauva, E.; Koivistoinen, P. 1995: Cholecalciferol contents in fortified margarine and milk. Finnish Journal of Dairy Science 51(2): 37-46
Kanekura, T.; Laulederkind, S.J.; Kirtikara, K.; Goorha, S.; Ballou, L.R. 1998: Cholecalciferol induces prostaglandin E2 biosynthesis and transglutaminase activity in human keratinocytes. Journal of Investigative Dermatology 111(4): 634-639
Yahav, S.; Buffenstein, R. 1993: Cholecalciferol supplementation alters gut function and improves digestibility in an underground inhabitant, the naked mole rat (Heterocephalus glaber), when fed on a carrot diet. British Journal of Nutrition 69(1): 233-241
Jolly, S.E.; Henderson, R.J.; Frampton, C.; Eason, C.T. 1995: Cholecalciferol toxicity and its enhancement by calcium carbonate in the common brushtail possum. Wildlife Research 22(5): 579-583
Corral Sánchez, M.A.; Gómez Sanz, R.; Alvarado Astudillo, A.; Rico Selas, P.; Moreno González, E. 1994: Cholecyst-thoracic fistula. A rare complication of lithiasic cholecystitis. Chest 106(4): 1303-1304
Khosla, R.; Singh, A.; Miedema, B.W.; Marshall, J.B. 1997: Cholecystectomy alleviates acalculous biliary pain in patients with a reduced gallbladder ejection fraction. Southern Medical Journal 90(11): 1087-1090
Goldbohm, R.A.; van den Brandt, P.A.; van 't Veer, P.; Dorant, E.; Sturmans, F.; Hermus, R.J. 1993: Cholecystectomy and colorectal cancer: evidence from a cohort study on diet and cancer. International Journal of Cancer 53(5): 735-739
Schoenemann, J.; Zeidler, J. 1997: Cholecystectomy and its sequelae. Zeitschrift fuer Gastroenterologie 35(2): 139-145
Bollschweiler, E.; Feussner, H.; Huber, F.; Siewert, J.R. 1993: Cholecystectomy as a risk factor for colorectal cancer? A meta-analysis. Langenbecks Archiv fuer Chirurgie 378(5): 304-312
Pélissier, E.P.; Blum, D.; Meyer, J.M.; Girard, J.F. 1992: Cholecystectomy by minilaparotomy without muscle section: a short-stay procedure. Hepato-Gastroenterology 39(4): 294-295
Fiori, E.; Leone, G.; Gazzanelli, S.; De-Cesare, A.; Bononi, M.; Lamazza, A.; Cangemi, V. 1993: Cholecystectomy due to calculosis: Analysis of a sample population. Gazzetta Medica Italiana Archivio per le Scienze Mediche 152(5): 169-173
French, A.L.; Beaudet, L.M.; Benator, D.A.; Levy, C.S.; Kass, M.; Orenstein, J.M. 1995: Cholecystectomy in patients with AIDS: Clinicopathologic correlations in 107 cases. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 21(4): 852-858
Wasmuth, H.H.; Guleng, R.J.; Danielsen, S. 1998: Cholecystectomy in the laparoscopic era. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(6): 876-879
Marti, W.; Herzog, U.; Kocher, T.; Schuppisser, J.P.; Ackermann, C.; Tondelli, P. 1994: Cholecystectomy today. A prospective study. Schweizerische Medizinische Wochenschrift 124(18): 763-767
Saad, A.M.; el Hassan, A.M. 1993: Cholecystectomy with and without drainage: a prospective randomised study. East African Medical Journal 70(8): 499-501
Pena, C.; Gudiol, F. 1996: Cholecystitis and cholangitis: Spectrum of bacteria and role of antibiotics. Digestive Surgery 13(4-5): 317-320
Miller, J.T.; De Odorico, I.; Marx, M.V. 1997: Cholecystojejunostomy varices demonstrated by enteroclysis. Abdominal Imaging 22(5): 474-476
Lança, A.J.; De Cabo, C.; Arifuzzaman, A.I.; Vaccarino, F.J. 1998: Cholecystokinergic innervation of nucleus accumbens subregions. Peptides 19(5): 859-868
Wiśniewska, R.J.; Wiśniewski, K. 1996: Cholecystokinin (CCK) and C-terminal fragments of CCK: Effects of CCK-33, CCK-8 and CCK-4 in the cardiovascular system of diabetic rats. General Pharmacology 27(2): 399-405
Zavros, Y.; Shulkes, A. 1997: Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep. Journal of Physiology (Cambridge) 505(3): 811-821
Beinfeld, M.C. 1996: Cholecystokinin (CCK) release from rat brain slices in vitro is enhanced by agents which elevate intracellular cAMP. Regulatory Peptides 67(2): 75-77
Pierzynowski, S., G.; Martensson, H.; Westrom, B., R.; Ahren, B.; Uvnas-Moberg, K.; Karlsson, B., W. 1993: Cholecystokinin (CCK-33) can stimulate pancreatic secretion by a local intestinal mechanism. Biomedical Research 14(3): 217-221
Balschun, D.; Reymann, K.G. 1994: Cholecystokinin (CCK-8S) prolongs 'unsaturated' theta-pulse induced long-term potentiation in rat hippocampal CA1 in vitro. Neuropeptides 26(6): 421-427
Weinberg, D.S.; Ruggeri, B.; Barber, M.T.; Biswas, S.; Miknyocki, S.; Waldman, S.A. 1997: Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. Journal of Clinical Investigation 100(3): 597-603
Valverde, O.; Maldonado, R.; Fournie-Zaluski, M.C.; Roques, B.P. 1994: Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins. Journal of Pharmacology and Experimental Therapeutics 270(1): 77-88
Chapman, V.; Honoré, P.; Buritova, J.; Besson, J.M. 1995: Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-FOS expression in the spinal cord of the rat. Neuroscience 67(3): 731-739
Blacker, D.; Broberger, C.; Ogren, S.O.; Hökfelt, T. 1997: Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencyclidine and dizocilpine maleate. Neuroscience 76(4): 1057-1067
Meister, B.; Broberger, C.; Villar, M.J.; Hökfelt, T. 1994: Cholecystokinin B receptor gene expression in hypothalamic neurosecretory neurons after experimental manipulations. Neuroendocrinology 60(5): 458-469
Luo, B.; Cheu, J.W.; Siegel, A. 1998: Cholecystokinin B receptors in the periaqueductal gray potentiate defensive rage behavior elicited from the medial hypothalamus of the cat. Brain Research 796(1-2): 27-37
Kaufmann, R.; Schafberg, H.; Rudroff, C.; Henklein, P.; Nowak, G. 1997: Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth. Neuropeptides 31(6): 573-583,.
Mercer, D.W.; Cross, J.M.; Barreto, J.C.; Strobel, N.H.; Russell, D.H.; Miller, T.A. 1995: Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandins. Digestive Diseases and Sciences 40(3): 651-660
O'Konski, M.S.; Pandol, S.J. 1993: Cholecystokinin JMV-180 and caerulein effects on the pancreatic acinar cell cytoskeleton. Pancreas 8(5): 638-646
Müller, W.; Heinemann, U.; Berlin, K. 1997: Cholecystokinin activates CCKB-receptor-mediated Ca-signaling in hippocampal astrocytes. Journal of Neurophysiology 78(4): 1997-2001
Sun, K.; Ferguson, A.V. 1997: Cholecystokinin activates area postrema neurons in rat brain slices. American Journal of Physiology 272(5 Part 2): R1625-R1630
Rinaman, L.; Hoffman, G.E.; Dohanics, J.; Le, W.W.; Stricker, E.M.; Verbalis, J.G. 1995: Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats. Journal of Comparative Neurology 360(2): 246-256
Davidowa, H.; Albrecht, D.; Gabriel, H.J.; Zippel, U. 1995: Cholecystokinin affects the neuronal discharge mode in the rat lateral geniculate body. Brain Research Bulletin 36(6): 533-537
Iwata, E.; Asanuma, M.; Kondo, Y.; Nishibayashi, S.; Matsuura, K.; Ogawa, N. 1995: Cholecystokinin alterations and effects of levodopa administration in the MPTP-treated mouse brain. Research Communications in Molecular Pathology and Pharmacology 88(1): 31-38
Swift, I.R.; Smith, J.P. 1994: Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer. Digestive Diseases and Sciences 39(5): 1007-1013
Maletínská, L.; Pírková, J.; Hlavácek, J.; Slaninová, J. 1998: Cholecystokinin analogs with suppressed central activities. Peptides 19(2): 301-308
Dabrowski, A.; Groblewski, G.E.; Schäfer, C.; Guan, K.L.; Williams, J.A. 1997: Cholecystokinin and EGF activate a MAPK cascade by different mechanisms in rat pancreatic acinar cells. American Journal of Physiology 273(5): C1472-C1479
Dulawa, S.C.; Vanderweele, D.A. 1994: Cholecystokinin and estradiol synergistically potentiate satiety in rats. Peptides 15(5): 913-918
Boulant, J.; Fioramonti, J.; Dapoigny, M.; Bommelaer, G.; Bueno, L. 1994: Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs. Gastroenterology 107(4): 1059-1066
Lines, C.; Challenor, J.; Traub, M. 1995: Cholecystokinin and anxiety in normal volunteers: An investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. British Journal of Clinical Pharmacology 39(3): 235-242
Kulkosky, P.J.; Clayborne, Y.J.; Sandoval, S.L. 1993: Cholecystokinin and bombesin inhibit ethanol and food intake in rats selectively bred for ethanol sensitivity. Alcoholism Clinical and Experimental Research 17(3): 545-551
Skinner, K.; Basbaum, A.I.; Fields, H.L. 1997: Cholecystokinin and enkephalin in brain stem pain modulating circuits. Neuroreport 8(14): 2995-2998
Ghilardi, J.R.; Allen, C.J.; Vigna, S.R.; McVey, D.C.; Mantyh, P.W. 1994: Cholecystokinin and neuropeptide Y receptors on single rabbit vagal afferent ganglion neurons: Site of prejunctional modulation of visceral sensory neurons. Brain Research 633(1-2): 33-40
Saleh, T.M.; Kombian, S.B.; Zidichouski, J.A.; Pittman, Q.J. 1997: Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro. Neuroscience 77(1): 23-35
Glasbrenner, B.; Dominguez-Munoz, E.; Riepl, R.L.; Vetsi, A.; Malfertheiner, P. 1995: Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy. Digestive Diseases and Sciences 40(2): 406-411
Dahl, D.; Lecompte, B.B.IIi 1994: Cholecystokinin and response modifications in hippocampal field CA1. Psychobiology 22(2): 134-140
Malm, D.; Giaever, A.; Vonen, B.; Florholmen, J. 1993: Cholecystokinin and somatostatin modulate the glucose-induced insulin secretion by different mechanisms in pancreatic islets. A study on phospholipase C activity and calcium requirement. Scandinavian Journal of Clinical and Laboratory Investigation 53(7): 671-676
Wakatsuki, K.; Saito, T.; Saeki, M.; Ninomiya, K.; Kasai, H.; Kimura, K.; Fujii, M. 1997: Cholecystokinin antagonistic activities of loxiglumide. Arzneimittel-Forschung 47(10): 1130-1133
Tang, N.M.; Dong, H.W.; Wang, X.M.; Tsui, Z.C.; Han, J.S. 1997: Cholecystokinin antisense RNA increases the analgesic effect induced by electroacupuncture or low dose morphine: conversion of low responder rats into high responders. Pain 71(1): 71-80
Stanfa, L.C.; Dickenson, A.H. 1993: Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation. British Journal of Pharmacology 108(4): 967-973
Melton, P.M.; Kopman, J.A.; Riley, A.L. 1993: Cholecystokinin as a stimulus in drug discrimination learning. Pharmacology Biochemistry and Behavior 44(2): 249-252
Balleine, B.; Davies, A.; Dickinson, A. 1995: Cholecystokinin attenuates incentive learning in rats. Behavioral Neuroscience 109(2): 312-319
Gué, M.; Tekamp, A.; Tabis, N.; Junien, J.L.; Buéno, L. 1994: Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: Role of the amygdala. Brain Research 658(1-2): 232-238
Jacquin, M.F.; Beinfeld, M.C.; Chiaia, N.L.; Zahm, D.S. 1992: Cholecystokinin concentrations and peptide immunoreactivity in the intact and deafferented medullary dorsal horn of the rat. Journal of Comparative Neurology 326(1): 22-43
Morino, P.; Mascagni, F.; McDonald, A.; Hökfelt, T. 1994: Cholecystokinin corticostriatal pathway in the rat: Evidence for bilateral origin from medial prefrontal cortical areas. Neuroscience 59(4): 939-952
Hirsh, A.J.; Cheeseman, C.I. 1998: Cholecystokinin decreases intestinal hexose absorption by a parallel reduction in SGLT1 abundance in the brush-border membrane. Journal of Biological Chemistry 273(23): 14545-14549
Gokin, A.P.; Hillsley, K.; Mawe, G.M. 1997: Cholecystokinin depolarizes guinea pig sphincter of Oddi neurons by activating CCK-A receptors. American Journal of Physiology 272(6 Pt 1): G1365-G1371
Ma, R.C.; Szurszewski, J.H. 1996: Cholecystokinin depolarizes neurons of cat pancreatic ganglion. Peptides 17(5): 775-783
Boden, P.R.; Higginbottom, M.; Hill, D.R.; Horwell, D.C.; Hughes, J.; Rees, D.C.; Roberts, E.; Singh, L.; Suman-Chauhan, N.; Woodruff, G.N. 1993: Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists. Journal of Medicinal Chemistry 36(5): 552-565
Niederau, C.; Mecklenbeck, W.; Heindges, T. 1993: Cholecystokinin does not delay gastric emptying of regular meals in healthy humans. Hepato-Gastroenterology 40(4): 380-383
Ephgrave, K.S.; Kleiman-Wexler, R.L.; Adair, C.G.; Skaar, L.M. 1992: Cholecystokinin does not mediate glucose's cytoprotective effects. Journal of Surgical Research 53(2): 145-151
McMillen, M.A.; Ferrara, A.; Adrian, T.E.; Margolis, D.S.; Schaefer, H.C.; Zucker, K.A. 1995: Cholecystokinin effect on human lymphocyte ionized calcium and mitogenesis. Journal of Surgical Research 58(2): 149-158
Fendt, M.; Koch, M.; Kungel, M.; Schnitzler, H.U. 1995: Cholecystokinin enhances the acoustic startle response in rats. Neuroreport 6(15): 2081-2084
Jarvis, C.R.; Van de Heijning, B.J.; Renaud, L.P. 1995: Cholecystokinin evokes vasopressin release from perfused hypothalamic-neurohypophyseal explants. Regulatory Peptides 56(2-3): 131-137
Davidowa, H.; Albrecht, D.; Gabriel, H.J.; Heublein, S.; Wetzel, K. 1995: Cholecystokinin excites neostriatal neurons in rats via CCKA or CCKB receptors. European Journal of Neuroscience 7(12): 2364-2369
Wang, Y.; Perng, S.L.; Lin, J.C.; Tsao, W.L. 1994: Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts. Experimental Neurology 130(2): 279-287
Pu, S.; Zhuang, H.; Lu, Z.; Wu, X.; Han, J. 1994: Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance. Brain Research. Molecular Brain Research 21(3-4): 183-189
Hlavacek, J.; Pirkova, J.; Zertova, M.; Pospisek, J.; Maletinska, L.; Slaninova, J. 1993: Cholecystokinin heptapeptide analogues containing amino acids with branched side-chains in positions 2, 5, and 7. Bioorganic Chemistry 21(1): 1-6
Löfberg, C.; Agren, H.; Harro, J.; Oreland, L. 1998: Cholecystokinin in CSF from depressed patients: Possible relations to severity of depression and suicidal behaviour. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 8(2): 153-157
van Megen, H.J.; Westenberg, H.G.; den Boer, J.A.; Kahn, R.S. 1996: Cholecystokinin in anxiety. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 6(4): 263-280
Morino, P.; Herrera-Marschitz, M.; Castel, M.N.; Ungerstedt, U.; Varro, A.; Dockray, G.; Hökfelt, T. 1994: Cholecystokinin in cortico-striatal neurons in the rat: Immunohistochemical studies at the light and electron microscopical level. European Journal of Neuroscience 6(5): 681-692
Geracioti, T.D.; Nicholson, W.E.; Orth, D.N.; Ekhator, N.N.; Loosen, P.T. 1993: Cholecystokinin in human cerebrospinal fluid: Concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism. Brain Research 629(2): 260-268
Verge, V.M.; Wiesenfeld-Hallin, Z.; Hökfelt, T. 1993: Cholecystokinin in mammalian primary sensory neurons and spinal cord: In situ hybridization studies in rat and monkey. European Journal of Neuroscience 5(3): 240-250
Abelson, J.L. 1995: Cholecystokinin in psychiatric research: A time for cautious excitement. Journal of Psychiatric Research 29(5): 389-396
Konturek, J.W.; Stoll, R.; Konturek, S.J.; Domschke, W. 1993: Cholecystokinin in the control of gastric acid secretion in man. Gut 34(3): 321-328
Konturek, J.W.; Stoll, R.; Gutwinska-Konturek, M.; Konturek, S.J.; Domschke, W. 1993: Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans. Scandinavian Journal of Gastroenterology 28(5): 401-407
Konturek, J.W.; Domschke, W. 1995: Cholecystokinin in the regulation of gastric acid secretion in healthy subjects and duodenal ulcer patients. Zeitschrift fuer Gastroenterologie 33(6): 372-375
Boulant, J.; Mathieu, S.; D'Amato, M.; Abergel, A.; Dapoigny, M.; Bommelaer, G. 1997: Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans. Gut 40(5): 575-581
Miller, K.K.; Hoffer, A.; Svoboda, K.R.; Lupica, C.R. 1997: Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(13): 4994-5003
Dawes, L.G.; Muldoon, J.P.; Greiner, M.A.; Bertolotti, M. 1997: Cholecystokinin increases bile acid synthesis with total parenteral nutrition but does not prevent stone formation. Journal of Surgical Research 67(1): 84-89
Reum, T.; Schäfer, U.; Marsden, C.A.; Fink, H.; Morgenstern, R. 1997: Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry. Neuropeptides 31(1): 82-88
Lignon, M.F.; Bernad, N.; Martinez, J. 1993: Cholecystokinin increases intracellular calcium concentration in the human JURKAT T lymphocyte cell line. European Journal of Pharmacology Molecular Pharmacology Section 11(3): 241-246
Wang, X.; Soltesz, V.; Axelson, J.; Andersson, R. 1996: Cholecystokinin increases small intestinal motility and reduces enteric bacterial overgrowth and translocation in rats with surgically induced acute liver failure. Digestion 57(1): 67-72
Kaufmann, R.; Schöneberg, T.; Lindschau, C.; Haller, H.; Ott, T. 1995: Cholecystokinin induced signaling in rat glioma C6 cells. Neuropeptides 29(5): 251-256
Boswell, T.; Li, Q. 1998: Cholecystokinin induces Fos expression in the brain of the Japanese quail. Hormones and Behavior 34(1): 56-66
Moran, T.H.; Kornbluh, R.; Moore, K.; Schwartz, G.J. 1994: Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites. Regulatory Peptides 52(3): 165-172
Schäfer, M.; Zhou, L.; Stein, C. 1998: Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue. Neuroscience 82(2): 603-611
Guirado, S.; Real, M.A.; Padial, J.; Andreu, M.J.; Dávila, J.C. 1998: Cholecystokinin innervation of the cerebral cortex in a reptile, the lizard, Psammodromus algirus. Brain Behavior and Evolution 51(2): 100-112
Schmidt, W.E.; Schenk, S.; Nustede, R.; Holst, J.J.; Fölsch, U.R.; Creutzfeldt, W. 1994: Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 107(6): 1610-1620
Burckhardt, B.; Delco, F.; Ensinck, J.W.; Meier, R.; Bauerfeind, P.; Aufderhaar, U.; Ketterer, S.; Gyr, K.; Beglinger, C. 1994: Cholecystokinin is a physiological regulator of gastric acid secretion in man. European Journal of Clinical Investigation 24(6): 370-376
Satoh, S.; Furuse, M.; Choi, Y.H.; Okumura, J. 1994: Cholecystokinin is not a major in the digestive system in the chicken. Experientia (Basel) 50(9): 812-814
Herrera-Marschitz, M.; Meana, J.J.; Hökfelt, T.; You, Z.B.; Morino, P.; Brodin, E.; Ungerstedt, U. 1992: Cholecystokinin is released from a crossed corticostriatal pathway. Neuroreport 3(10): 905-908
Virgo, L.; Humphries, C.; Mortimer, A.; Barnes, T.; Hirsch, S.; de Belleroche, J. 1995: Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia. Biological Psychiatry 37(10): 694-701
Purushotham, K.R.; Blazsek, J.; Humphreys-Beher, M.G.; Zelles, T. 1993: Cholecystokinin modulates isoproterenol induced changes in rat parotid gland. Comparative Biochemistry and Physiology. C Comparative Pharmacology and Toxicology 106(1): 249-254
Markowski, V.P.; Hull, E.M. 1995: Cholecystokinin modulates mesolimbic dopaminergic influences on male rat copulatory behavior. Brain Research 699(2): 266-274
Alverdy, J.; Stern, E.; Poticha, S.; Baunoch, D.; Adrian, T. 1997: Cholecystokinin modulates mucosal immunoglobulin A function. Surgery 122(2): 386-92; Discussion 392-3
Valverde, O.; Roques, B.P. 1998: Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats. Neuroscience Letters 244(1): 37-40
Bishop, G.A. 1996: Cholecystokinin modulation of spontaneous and excitatory amino acid-induced activity in the opossum cerebellum. Neuropeptides 30(6): 533-540
Pu, S.F.; Zhuang, H.X.; Han, J.S. 1994: Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor. Brain Research 657(1-2): 159-164
Szelényi, Z.; Barthó, L.; Székely, M.; Romanovsky, A.A. 1994: Cholecystokinin octapeptide (CCK-8) injected into a cerebral ventricle induces a fever-like thermoregulatory response mediated by type B CCK-receptors in the rat. Brain Research 638(1-2): 69-77
Hudson, G.M.; Marquis, K.L.; Stamidis, H.; Young, G.A. 1992: Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively. European Journal of Pharmacology 221(2-3): 217-222
Li, X.; Chadi, G.; Fuxe, K. 1995: Cholecystokinin octapeptide and the D2 antagonist raclopride induce Fos-like immunoreactivity in the shell part of the rat nucleus accumbens via different mechanisms. Brain Research 684(2): 225-229
Morawska-Barszczewska, J.; Guzek, J.W.; Kaczorowska-Skóra, J. 1996: Cholecystokinin octapeptide and the daily rhythm of vasopressin and oxytocin release. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 104(2): 164-171
Richardson, R.D.; Boswell, T.; Weatherford, S.C.; Wingfield, J.C.; Woods, S.C. 1993: Cholecystokinin octapeptide decreases food intake in white-crowned sparrows. American Journal of Physiology 264(5 Part 2): R852-R856
Li, X.M.; Hedlund, P.B.; Fuxe, K. 1995: Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections. European Journal of Neuroscience 7(5): 962-971
Padfield, P.J.; Panesar, N. 1998: Cholecystokinin octapeptide inhibits Ca2+-dependent amylase secretion from permeabilized pancreatic acini by blocking the MgATP-dependent priming of exocytosis. Biochemical Journal 330: 329-334
Rakovska, A. 1995: Cholecystokinin [corrected] octapeptide modulates dopamine release in rat striatum. Neuroscience Letters 195(3): 151-154
Liu, N.J.; Xu, T.; Xu, C.; Li, C.Q.; Yu, Y.X.; Kang, H.G.; Han, J.S. 1995: Cholecystokinin octapeptide reverses mu-opioid-receptor-mediated inhibition of calcium current in rat dorsal root ganglion neurons. Journal of Pharmacology and Experimental Therapeutics 275(3): 1293-1299
Xu, T.; Liu, N.J.; Li, C.Q.; Shangguan, Y.; Yu, Y.X.; Kang, H.G.; Han, J.S. 1996: Cholecystokinin octapeptide reverses the kappa-opioid-receptor-mediated depression of calcium current in rat dorsal root ganglion neurons. Brain Research 730(1-2): 207-211
Fraser, R.; Fone, D.; Horowitz, M.; Dent, J. 1993: Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans. Gut 34(1): 33-37
Székely, M.; Szelényi, Z.; Balaskó, M. 1994: Cholecystokinin participates in the mediation of fever. Pflugers Archiv: European Journal of Physiology 428(5-6): 671-673
Löfberg, C.; Harro, J.; Gottfries, C.G.; Oreland, L. 1996: Cholecystokinin peptides and receptor binding in Alzheimer's disease. Journal of Neural Transmission 103(7): 851-860
Löfberg, C.; Harro, J.; Matto, V.; Oreland, L. 1998: Cholecystokinin peptides and receptor binding in rat brain after DSP-4 treatment. Neuropeptides 32(2): 103-108
Harro, J.; Löfberg, C.; Rehfeld, J.F.; Oreland, L. 1996: Cholecystokinin peptides and receptors in the rat brain during stress. Naunyn-Schmiedeberg's Archives of Pharmacology 354(1): 59-66
Gunnarsson, T.; Eklundh, T.; Eriksson, M.; Qureshi, G.A.; Sjöberg, S.; Nordin, C. 1997: Cholecystokinin peptides in cerebrospinal fluid: A study in healthy male subjects. Regulatory Peptides 68(1): 57-61
Yoshida, H.; Tsunoda, Y.; Owyang, C. 1997: Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways. American Journal of Physiology 273(3 Pt 1): G735-G747
Blommaert, A.G.; Weng, J.H.; Dorville, A.; McCort, I.; Ducos, B.; Durieux, C.; Roques, B.P. 1993: Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties. Journal of Medicinal Chemistry 36(20): 2868-2877
Legido, A.; Adler, M.W.; Karkanias, C.; Geller, E.B.; Bradley, E.; Greenstein, J.I.; Grover, W.D. 1995: Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors. Neuropeptides 28(2): 107-113
Duan, R.D.; Williams, J.A. 1994: Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. American Journal of Physiology 267(3 Part 1): G401-G408
Hirata, M.; Itoh, M.; Tsuchida, A.; Ooishi, H.; Hanada, K.; Kajiyama, G. 1996: Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS Letters 383(3): 241-244
Welin, M.; Harro, J.; Yukhananov, R.; Nyberg, F.; Oreland, L. 1994: Cholecystokinin receptor binding in morphine analgesia: tolerance, withdrawal and abstinence. Neuropeptides 26(6): 379-383
Povoski, S.P.; Zhou, W.; Longnecker, D.S.; Bell, R.H. 1994: Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Oncology Research 6(9): 411-417
Kirouac, G.J.; Ganguly, P.K. 1993: Cholecystokinin receptor density in the striatum of the spontaneously hypertensive rat. Brain Research 604(1-2): 338-341
Smith, J.P.; Rickabaugh, C.A.; McLaughlin, P.J.; Zagon, I.S. 1993: Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. American Journal of Physiology 265(1 Pt 1): G149-G155
Harro, J.; Oreland, L. 1993: Cholecystokinin receptors and memory: A radial maze study. Pharmacology Biochemistry and Behavior 44(3): 509-517
Bluthé, R.M.; Michaud, B.; Kelley, K.W.; Dantzer, R. 1997: Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice. Physiology and Behavior 62(2): 385-389
Tang, C.; Biemond, I.; Lamers, C.B. 1996: Cholecystokinin receptors in human pancreas and gallbladder muscle: A comparative study. Gastroenterology 111(6): 1621-1626
Mandair, K.K.; Towner, P.; Stamford, I.F.; Morris, J.D.; Harper, E.; Benjamin, I.S.; Tavares, I.A. 1998: Cholecystokinin receptors in human pancreatic cancer cell lines. European Journal of Cancer 34(9): 1455-1459
Watanabe, K.; Yano, S.; Mitani, H. 1994: Cholecystokinin receptors involved in the central and peripheral nervous control mechanisms in gastric acid secretion. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 104(3): 153-162
Eckel, L.A.; Ossenkopp, K.P. 1995: Cholecystokinin reduces ingestive taste reactivity responses to water in fluid-replete but not fluid-deprived rats. Physiology and Behavior 57(3): 599-603
de Dios, I.; Rodriguez, A.I.; García-Montero, A.C.; Orfao, A.; Manso, M.A. 1997: Cholecystokinin regulates glycoprotein membrane composition of rat pancreatic zymogen granules. Biochimica Et Biophysica Acta 1326(1): 131-137
Cox, J.E. 1998: Cholecystokinin satiety involves CCKA receptors perfused by the superior pancreaticoduodenal artery. American Journal of Physiology 274(5): R1390-R1396
Dabrowski, A.; VanderKuur, J.A.; Carter-Su, C.; Williams, J.A. 1996: Cholecystokinin stimulates formation of shc-grb2 complex in rat pancreatic acinar cells through a protein kinase C-dependent mechanism. Journal of Biological Chemistry 271(43): 27125-27129
Perera, A.D.; Verbalis, J.G.; Mikuma, N.; Majumdar, S.S.; Plant, T.M. 1993: Cholecystokinin stimulates gonadotropin-releasing hormone release in the monkey (Macaca mulatta). Endocrinology 132(4): 1723-1728
Groblewski, G.E.; Grady, T.; Mehta, N.; Lambert, H.; Logsdon, C.D.; Landry, J.; Williams, J.A. 1997: Cholecystokinin stimulates heat shock protein 27 phosphorylation in rat pancreas both in vivo and in vitro. Gastroenterology 112(4): 1354-1361
Groblewski, G.E.; Wang, Y.; Ernst, S.A.; Kent, C.; Williams, J.A. 1995: Cholecystokinin stimulates the down-regulation of CTP:phosphocholine cytidylyltransferase in pancreatic acinar cells. Journal of Biological Chemistry 270(3): 1437-1442
Reidelberger, R.D.; Varga, G.; Liehr, R.M.; Castellanos, D.A.; Rosenquist, G.L.; Wong, H.C.; Walsh, J.H. 1994: Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats. American Journal of Physiology 267(4 Part 2): R901-R908
Schmassmann, A.; Garner, A.; Flogerzi, B.; Hasan, M.Y.; Sanner, M.; Varga, L.; Halter, F. 1994: Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Gut 35(2): 270-274
Greenstein, R.J.; Colucci, R.D.; Ybanez, M.M.; Zhang, R.L.; Mcelhinney, A.J.; Bauman, W.A. 1992: Cholecystokinin upregulation during intestinal repair. Journal of Surgical Research 53(1): 12-16
Mauri, M.C.; Rudelli, R.; Vanni, S.; Panza, G.; Sicaro, A.; Audisio, D.; Sacerdote, P.; Panerai, A.E. 1998: Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls. Psychiatry Research 78(1-2): 45-50
Qian, M.; Johnson, A.E.; Källström, L.; Carrer, H.; Södersten, P. 1997: Cholecystokinin, dopamine D2 and N-methyl-D-aspartate binding sites in the nucleus of the solitary tract of the rat: possible relationship to ingestive behavior. Neuroscience 77(4): 1077-1089
Eilertson, C.D.; Carneiro, N.M.; Kittilson, J.D.; Comley, C.; Sheridan, M.A. 1996: Cholecystokinin, neuropeptide y and galanin modulate the release of pancreatic somatostatin-25 and somatostatin-14 in vitro. Regulatory Peptides 63(2-3): 105-112
Li, B.H.; Rowland, N.E. 1994: Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain. Regulatory Peptides 50(3): 223-233
Oeth, K.M.; Lewis, D.A. 1992: Cholecystokinin- and dopamine-containing mesencephalic neurons provide distinct projections to monkey prefrontal cortex. Neuroscience Letters 145(1): 87-92
Holm, I.E.; Geneser, F.A.; Zimmer, J. 1993: Cholecystokinin-, enkephalin-, and substance P-like immunoreactivity in the dentate area, hippocampus, and subiculum of the domestic pig. Journal of Comparative Neurology 331(3): 310-325
You, Z.B.; Godukhin, O.; Goiny, M.; Nylander, I.; Ungerstedt, U.; Terenius, L.; Hökfelt, T.; Herrera-Marschitz, M. 1997: Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes. Naunyn-Schmiedeberg's Archives of Pharmacology 355(5): 576-581
Monstein, H.J.; Nylander, A.G.; Salehi, A.; Chen, D.; Lundquist, I.; Håkanson, R. 1996: Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scandinavian Journal of Gastroenterology 31(4): 383-390
Derrien, M.; Noble, F.; Maldonado, R.; Roques, B.P. 1993: Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice. Neuroscience Letters 160(2): 193-196
Feinle, C.; D'amato, M.; Read, N.W. 1996: Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 110(5): 1379-1385
Yamazaki, Y.; Shinagawa, K.; Takeda, H.; Kobayashi, M.; Akahane, M.; Ajisawa, Y. 1995: Cholecystokinin-A specific antagonism of KSG-504 to cholecystokinin receptor binding and pancreatic secretion in mammals. Japanese Journal of Pharmacology 69(4): 367-373
Ding, X.Q.; Chen, D.; Håkanson, R. 1995: Cholecystokinin-B Receptor Ligands of the Dipeptoid Series Act as Agonists on Rat Stomach Histidine Decarboxylase. Gastroenterology 109(4): 1181-1187
Oiry, C.; Gagne, D.; Cottin, E.; Bernad, N.; Galleyrand, J.C.; Bergé, G.; Lignon, M.F.; Eldin, P.; Le Cunff, M.; Léger, J.; Clerc, P.; Fourmy, D.; Martinez, J. 1997: CholecystokininB receptor from human Jurkat lymphoblastic T cells is involved in activator protein-1-responsive gene activation. Molecular Pharmacology 52(2): 292-299
Ding, X.Q.; Lindström, E.; Håkanson, R. 1997: Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells. Pharmacology and Toxicology 81(1): 19-25
Taniguchi, T.; Matsui, T.; Ito, M.; Murayama, T.; Tsukamoto, T.; Katakami, Y.; Chiba, T.; Chihara, K. 1994: Cholecystokinin-B/gastrin receptor signaling pathway involves tyrosine phosphorylations of p125FAK and p42MAP. Oncogene 9(3): 861-867
Matsumori, Y.; Katakami, N.; Ito, M.; Taniguchi, T.; Iwata, N.; Takaishi, T.; Chihara, K.; Matsui, T. 1995: Cholecystokinin-B/gastrin receptor: A novel molecular probe for human small cell lung cancer. Cancer Research 55(2): 276-279
Taniguchi, T.; Takaishi, K.; Murayama, T.; Ito, M.; Iwata, N.; Chihara, K.; Sasaki, T.; Takai, Y.; Matsui, T. 1996: Cholecystokinin-B/gastrin receptors mediate rapid formation of actin stress fibers. Oncogene 12(6): 1357-1360
Rakovska, A. 1995: Cholecystokinin-GABA interactions in rat striatum. Neuropeptides 29(5): 257-262
Sjödin, L.; Viitanen, E.; Gylfe, E. 1997: Cholecystokinin-JMV-180 and pilocarpine are potent inhibitors of cholecystokinin and carbachol actions on guinea pig pancreatic acinar cells. Naunyn-Schmiedeberg's Archives of Pharmacology 355(5): 631-637
Cunningham, M.E.; Shaw-Stiffel, T.A.; Bernstein, L.H.; Tinghitella, T.J.; Claus, R.E.; Brogan, D.A.; McMillen, M.A. 1995: Cholecystokinin-stimulated monocytes produce inflammatory cytokines and eicosanoids. American Journal of Gastroenterology 90(4): 621-626
Yu, P.; De Petris, G.; Biancani, P.; Amaral, J.; Behar, J. 1994: Cholecystokinin-coupled intracellular signaling in human gallbladder muscle. Gastroenterology 106(3): 763-770
Sirinathsinghji, D.J.; Heavens, R.P.; Torres, E.M.; Dunnett, S.B. 1993: Cholecystokinin-dependent regulation of host dopamine inputs to striatal grafts. Neuroscience 53(3): 651-663
Phillips, G.D.; Le Noury, J.; Wolterink, G.; Donselaar-Wolterink, I.; Robbins, T.W.; Everitt, B.J. 1993: Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement. Behavioural Brain Research 55(2): 223-231
Albrecht, D.; Müller, R.; Zippel, U.; Gabriel, H.J.; Henklein, P.; Davidowa, H. 1994: Cholecystokinin-induced activity changes of dorsal lateral geniculate neurons in rats. Neuroscience 59(4): 953-960
Williams, C.L.; Rosenfeld, G.C.; Burks, T.F. 1997: Cholecystokinin-induced antinociception is not blocked by CCK-A or CCK-B receptor antagonists. Peptides 18(3): 409-414
Rao, R.V.; Hadac, E.M.; Roettger, B.F.; Miller, L.J. 1997: Cholecystokinin-induced desensitization, receptor phosphorylation, and internalization in the CHP212 neuroblastoma cell line. Journal of Neurochemistry 68(6): 2356-2362
Pietrowsky, R.; Rudolf, S.; Mölle, M.; Fehm, H.L.; Born, J. 1997: Cholecystokinin-induced effects on selective attention depend on level of activation. Neuropsychobiology 36(2): 87-95
Mercer, D.W.; Klemm, K.; Cross, J.M.; Smith, G.S.; Cashman, M.; Miller, T.A. 1996: Cholecystokinin-induced protection against gastric injury is independent of endogenous somatostatin. American Journal of Physiology 271(4 Part 1): G692-G700
Kirouac, G.J.; Ganguly, P.K. 1995: Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat. Brain Research 689(2): 245-253
Long, S.K. 1993: Cholecystokinin-induced ventral root depolarization of neonate rat hemicord in vitro. General Pharmacology 24(1): 171-175
Bennis, M.; Repérant, J.; Ward, R.; Ba M'hamed, S.; Medina, M. 1997: Cholecystokinin-like systems in the chameleon brain. Anatomy and Embryology 196(3): 261-268
Ngezahayo, A.; Lang, F.; Kolb, H.A. 1995: Cholecystokinin-octapeptide affects the fluorescence signal of a single pancreatic acinar cell loaded with the acrylodan-labelled MARCKS peptide, a protein kinase C substrate. Pflugers Archiv: European Journal of Physiology 429(6): 805-808
Maurice, T.; Hiramatsu, M.; Kameyama, T.; Hasegawa, T.; Nabeshima, T. 1994: Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice. Journal of Pharmacology and Experimental Therapeutics 269(2): 665-673
Willems, P.H.; Van Emst-de Vries, S.E.; De Pont, J.J. 1995: Cholecystokinin-stimulated enzyme secretion from dispersed rabbit pancreatic acinar cells: Phosphorylation-dependent changes in potency and efficacy. Pflugers Archiv: European Journal of Physiology 430(5): 626-635
García, L.J.; Rosado, J.A.; González, A.; Jensen, R.T. 1997: Cholecystokinin-stimulated tyrosine phosphorylation of p125FAK and paxillin is mediated by phospholipase C-dependent and -independent mechanisms and requires the integrity of the actin cytoskeleton and participation of p21rho. Biochemical Journal 327: 461-472
Qureshi, G.A.; Ansari, A.; Halawa, A.; Minami, M.; Parvez, S.H. 1998: Cholecystokinins and their coexistence with catecholamines in cerebrospinal fluid of patients with some neurological disorders. Biogenic Amines 14(2): 101-115
Bereznowski, A. 1994: Cholecystolithiasis in a dog. Medycyna Weterynaryjna 50(11): 569-570
Hojs, R. 1995: Cholecystolithiasis in patients with end-stage renal disease treated with haemodialysis: a study of prevalence. American Journal of Nephrology 15(1): 15-17
Brogdon, B.G.; Neuffer, F.H.; Siner, J.R. 1996: Choledochal 'clipoliths' after cholecystectomy. Southern Medical Journal 89(11): 1111-1113
Shanley, D.J.; Gagliardi, J.A.; Daum-Kowalski, R. 1994: Choledochal cyst complicating pregnancy: Antepartum diagnosis with MRI. Abdominal Imaging 19(1): 61-63
Kullendorff, C.M. 1994: Choledochal cyst in childhood. Annales Chirurgiae et Gynaecologiae 83(3): 261-264
Hsu, C.C.; Lin, L.H.; Chen, D.F. 1997: Choledochal cyst in infancy: report of two cases. Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 38(4): 300-302
Lai, H.C.; Wu, Y.K.; Lai, H.S. 1996: Choledochal cyst in neonates. Journal of the Formosan Medical Association 95(7): 567-571
Niemann, H.; Schippers, E.; Truong, S.; Schumpelick, V. 1994: Choledochal cyst type I (Todani). Chirurg 65(12): 1147-1149
Tajiri, K.; Takenawa, H.; Yamaoka, K.; Yamane, M.; Marumo, F.; Sato, C. 1997: Choledochal cyst with adenocarcinoma in the cystically dilated intrahepatic bile duct. Abdominal Imaging 22(2): 190-193
Kiguli-Malwadde, E.; Kawooya, M.G. 1996: Choledochal cyst: an atypical presentation of Caroli's disease. Central African Journal of Medicine 42(11): 329-330
Shian, W.J.; Wang, Y.J.; Chi, C.S. 1993: Choledochal cysts: a nine-year review. Acta Paediatrica 82(4): 383-386
Stringer, M.D.; Dhawan, A.; Davenport, M.; Mieli-Vergani, G.; Mowat, A.P.; Howard, E.R. 1995: Choledochal cysts: lessons from a 20 year experience. Archives of Disease in Childhood 73(6): 528-531
Akhan, O.; Demirkazik, F.B.; Ozmen, M.N.; Ariyürek, M. 1994: Choledochal cysts: Ultrasonographic findings and correlation with other imaging modalities. Abdominal Imaging 19(3): 243-247
Peiper, M.; Emmermann, A.; Rogiers, X.; Broelsch, C.E. 1994: Choledochal duct-stenosis caused by metal clips after laparoscopic cholecystectomy. Chirurg 65(3): 217-220
Audry, G.; Giral, P.; Bonnefis, M.T.; Legendre, C.; Myara, A.; Poupon, R. 1993: Choledocho-ureteral anastomosis in the rat. A new experimental model of long-term, total, internal bile diversion. Journal of Hepatology 17(3): 373-376
Tajiri, H. 1996: Choledochocele-containing stones. American Journal of Gastroenterology 91(5): 1046-1048
Masetti, R.; Antinori, A.; Coppola, R.; Coco, C.; Mattana, C.; Crucitti, A.; La Greca, A.; Fadda, G.; Magistrelli, P.; Picciocchi, A. 1996: Choledochocele: Changing trends in diagnosis and management. Surgery Today 26(4): 281-285
Luo, H. 1994: Choledochocyst Excision and Re-establishment of Biliary Tract in Children. Acta Academiae Medicinae Hubei 15(3): 289-291
Lahlou, M.K.; Chad, B.; Zizi, A.; Mohammadine, A.; Benamer, S.; Essadel, A.; Abbassi, A.; Taghy, A.; Belmahi, A. 1997: Choledochoduodenal fistula due to peptic ulcer. a review of 4 cases. Semaine des Hopitaux 73(25-26): 820-824
Iso, Y.; Yoh, R.; Okita, K.; Murakami, N.; Nozoe, T.; Funahashi, S.; Adachi, Y.; Matsumata, T.; Sugimachi, K. 1996: Choledochoduodenal fistula: a complication of a penetrated duodenal ulcer. Hepato-Gastroenterology 43(9): 489-491
Soehendra, N.; Seifert, H.; Thonke, F.; Seitz, U.; Wang, Y.G. 1994: Choledocholithiasis - endoscopic techniques. Chirurg 65(5): 413-417
Boeckl, O.; Sungler, P.; Heinerman, P.M.; Lexer, G. 1994: Choledocholithiasis--therapeutic splitting. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(5): 424-429
Becker, C.D.; Grossholz, M.; Becker, M.; Mentha, G.; de Peyer, R.; Terrier, F. 1997: Choledocholithiasis and bile duct stenosis: diagnostic accuracy of MR cholangiopancreatography. Radiology 205(2): 523-530
Niederau, C.; Schumacher, B.; Luebke, H.; Frieling, T.; Haeussinger, D. 1996: Choledocholithiasis and obstructive cholangitis: An endoscopic or laparoscopic approach?. Digestive Surgery 13(4-5): 321-327
Ishitani, M.B.; Shaul, D.B.; Padua, E.A.; McAlpin, C.A. 1996: Choledocholithiasis in a premature neonate. Journal of Pediatrics 128(6): 853-855
Goldman, D.E.; Gholson, C.F. 1995: Choledocholithiasis in patients with normal serum liver enzymes. Digestive Diseases and Sciences 40(5): 1065-1068
Chan, Y.L.; Chan, A.C.; Lam, W.W.; Lee, D.W.; Chung, S.S.; Sung, J.J.; Cheung, H.S.; Li, A.K.; Metreweli, C. 1996: Choledocholithiasis: comparison of MR cholangiography and endoscopic retrograde cholangiography. Radiology 200(1): 85-89
Robles Campos, R.; Parrilla Paricio, P.; Garcia Ayllon, J.; Lujan Mompean, J.A.; Cifuentes Tebar, J.; Candel Arenas, M.F.; Sanchez Bueno, F.; Ramirez Romero, P. 1992: Choledochoscopy reduces unnecessary papillary surgery. Digestive Surgery 9(3): 141-144
Shafik, A. 1998: Choledochosphincter inhibitory reflex: identification of the reflex in dogs and its significance. Journal of Surgical Research 78(1): 7-10
Montini, M.; Gianola, D.; Pagani, M.D.; Pedroncelli, A.; Caldara, R.; Gherardi, F.; Bonelli, M.; Lancranjan, I.; Pagani, G. 1994: Cholelithiasis and acromegaly: Therapeutic strategies. Clinical Endocrinology 40(3): 401-406
Wu, C.C.; Chen, C.Y.; Wu, T.C.; Iiu, T.J.; P'eng, P.K. 1995: Cholelithiasis and cholecystitis after gastrectomy for gastric carcinoma: a comparison of lymphadenectomy of varying extent. Hepato-Gastroenterology 42(6): 867-872
Tsimoyiannis, E.C.; Antoniou, N.C.; Tsaboulas, C.; Papanikolaou, N. 1994: Cholelithiasis during pregnancy and lactation. Prospective study. European Journal of Surgery 160(11): 627-631
Brandt, J.R.; Joseph, M.W.; Fouser, L.S.; Tarr, P.I.; Zelikovic, I.; Mcdonald, R.A.; Avner, E.D.; Mcafee, N.G.; Watkins, S.L. 1998: Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatric Nephrology 12(3): 222-225
Aziz, M.R.; Wandwi, W.B. 1995: Cholelithiasis in Dar es Salaam, Tanzania. Central African Journal of Medicine 41(10): 308-312
Ho, K.J.; Lin, X.Z.; Yu, S.C.; Chen, J.S.; Wu, C.Z. 1995: Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Digestive Diseases and Sciences 40(9): 1963-1973
Kõse, G.; Ozkan, H.; Ozdamar, F.; Kavukçu, S.; Ozaksoy, D. 1993: Cholelithiasis in cervico-oculo-acoustic (Wildervanck's) syndrome. Acta Paediatrica 82(10): 890-891
Okuonghae, H.O.; Szlachetka, R.; Sagay, A.S. 1993: Cholelithiasis in children with homozygous sickle cell anaemia in northern Nigeria. Tropical and Geographical Medicine 45(1): 44-45
Jawad, A.J.; Al-Rabeeah, A.; Al-Sunnie, A.; Samarkandi, A.; Al-Samarrai, A.I.; Al-Rashed, R. 1998: Cholelithiasis in infancy and childhood. Saudi Medical Journal 19(4): 406-408
Debray, D.; Pariente, D.; Gauthier, F.; Myara, A.; Bernard, O. 1993: Cholelithiasis in infancy: a study of 40 cases. Journal of Pediatrics 122(3): 385-391
Aynaci, F.M.; Erduran, E.; Mocan, H.; Okten, A.; Sarpkaya, A.O. 1995: Cholelithiasis in infants with Down syndrome: report of two cases. Acta Paediatrica 84(6): 711-712
Lowell, J.A.; Stratta, R.J.; Taylor, R.J.; Bynon, J.S.; Larsen, J.L.; Nelson, N.L. 1993: Cholelithiasis in pancreas and kidney transplant recipients with diabetes. Surgery 114(4): 858
Castellano, L.; De Sio, I.; Silvestrino, F.; Marmo, R.; Del Vecchio Blanco, C. 1995: Cholelithiasis in patients with chronic active liver disease: evaluation of risk factors. Italian Journal of Gastroenterology 27(8): 425-429
Hansen, G.C.; Duerinckx, A.J.; Fymat, A.; Wong, L.; Ngo, C. 1994: Cholelithiasis in the gravid Hispanic population. Journal of Clinical Ultrasound: Jcu 22(3): 187-191
Chiedozi, L.C.; al Hadi, F.H.; Salem, M.; Desouky, M.M. 1998: Cholelithiasis in young Saudi women. East African Medical Journal 75(3): 184-187
Potashov, L.V.; Figurina, T.D.; Kolpakov, N.A. 1993: Cholelithiasis in young persons. Klinicheskaya Meditsina 71(1): 25-27
Tillmann, F.; Gruen, R.; Girona, J. 1997: Cholelithiasis, cholecystectomy and colorectal cancer: A case-control study. Zeitschrift fuer Gastroenterologie 35(8): 615-620
Lee, V.S.; Paulson, E.K.; Libby, E.; Flannery, J.E.; Meyers, W.C. 1993: Cholelithoptysis and cholelithorrhea: rare complications of laparoscopic cholecystectomy. Gastroenterology 105(6): 1877-1881
Barnard, S.P.; Pallister, I.; Hendrick, D.J.; Walter, N.; Morritt, G.N. 1995: Cholelithoptysis and empyema formation after laparoscopic cholecystectomy. Annals of Thoracic Surgery 60(4): 1100-1102
Breslin, A.B.; Wadhwa, V. 1996: Cholelithoptysis: a rare complication of laparoscopic cholecystectomy. Medical Journal of Australia 165(7): 373-374
Hasan, J.A.; Bernstein, D.; Huq, A.; Loomis, L.; Tamplin, M.L.; Colwell, R.R. 1994: Cholera DFA: an improved direct fluorescent monoclonal antibody staining kit for rapid detection and enumeration of Vibrio cholerae O1. FEMS Microbiology Letters 120(1-2): 143-148
Ransjö, M.; Lerner, U.H.; Ljunggren, O. 1994: Cholera toxin-stimulated bone resorption in cultured mouse calvarial bones not inhibited by calcitonin: a possible interaction at the stimulatory G protein. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 9(12): 1927-1934
Van Dyke, R.W. 1997: Cholera and pertussis toxins increase acidification of endocytic vesicles without altering ion conductances. American Journal of Physiology 272(4 Part 1): C1123-C1133
Cachero, T.G.; Rigual, R.; Rocher, A.; Gonzalez, C. 1996: Cholera and pertussis toxins reveal multiple regulation of cAMP levels in the rabbit carotid body. European Journal of Neuroscience 8(11): 2320-2327
Vugia, D.J.; Shefer, A.M.; Douglas, J.; Greene, K.D.; Bryant, R.G.; Werner, S.B. 1997: Cholera from raw seaweed transported from the Philippines to California. Journal of Clinical Microbiology 35(1): 284-285
Anonymous 1996: Cholera in Goma, July 1994. Bioforce. Revue d'Epidemiologie et de Sante Publique 44(4): 358-363
Fica, C.Alberto, E.; Cabello, C.; Felipe, A. 1992: Cholera in Latin America. Interciencia 17(5): 276-283, 314
Mamaeva, S.M.; Moskvitina, E.A.; Onishchenko, G.G.; Adzieva, R.G.; Kokushkin, A.M. 1995: Cholera in Makhachkala at the period of the epidemic of 1994. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1995(2): 46-50
Ries, A.A.; Vugia, D.J.; Beingolea, L.; Palacios, A.M.; Vasquez, E.; Wells, J.G.; Garcia Baca, N.; Swerdlow, D.L.; Pollack, M.; Bean, N.H. 1992: Cholera in Piura, Peru: a modern urban epidemic. Journal of Infectious Diseases 166(6): 1429-1433
Sheikh, A.; Khan, A.; Malik, T.; Fisher Hoch, S.P. 1997: Cholera in a developing megacity; Karachi, Pakistan. Epidemiology and Infection 119(3): 287-292,.
Lim-Quizon, M.C.; Benabaye, R.M.; White, F.M.; Dayrit, M.M.; White, M.E. 1994: Cholera in metropolitan Manila: foodborne transmission via street vendors. Bulletin of the World Health Organization 72(5): 745-749
Arutiunov, I.I.; Amirkhanov, A.A.; Bazarganov, M.M.; Cherepakhina, I.Ia.; Nekliaeva, V.N.; Omarova, A.A. 1995: Cholera in a remote region of Dagestan. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii Suppl 2: 40-43
Nair, G.B.; Shinoda, S. 1995: Cholera in the 1990s: A disease on the rampage. Japanese Journal of Toxicology and Environmental Health 41(4): 239-249
Onishchenko, G.G.; Lomov, Y.M.; Moskvitina, E.A.; Podosinnikova, L.S.; Moiseeva, A.V.; Alekseenko, V.V.; Chebotar', I.F.; Shestialtynova, I.S.; Vlasov, V.P. 1993: Cholera in the Ukraine and Moldova at the period of the seventh pandemic. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1993(2): 52-57
Weber, J.T.; Levine, W.C.; Hopkins, D.P.; Tauxe, R.V. 1994: Cholera in the United States, 1965-1991. Risks at home and abroad. Archives of Internal Medicine 154(5): 551-556
Onishchenko, G.G.; Lomov, Y.M.; Moskvitina, E.A. 1995: Cholera in the republic of Daghestan. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1995(2): 3-8
Bhadra, R.K.; Roychoudhury, S.; Banerjee, R.K.; Kar, S.; Majumdar, R.; Sengupta, S.; Chatterjee, S.; Khetawat, G.; Das, J. 1995: Cholera toxin (CTX) genetic element in Vibrio cholerae O139. Microbiology 141: 1977-1983
Muller, C.P.; Beauverger, P.; Schneider, F.; Jung, G.; Brons, N.H. 1995: Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus. Journal of General Virology 76: 1371-1380
O'hagan, D., T.; Mcgee, J.P.; Lindblad, M.; Holmgren, J. 1995: Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization. International Journal of Pharmaceutics (Amsterdam) 119(2): 251-255
Li, T.K.; Fox, B.S. 1996: Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone. International Immunology 8(12): 1849-1856
Iwanaga, T.; Ohtsuka, H. 1994: Cholera toxin B subunit shows more intense affinity to Schwann cells than neurons: In situ and in vivo staining. Acta Medica et Biologica 42(1): 19-24
Sun, J.B.; Holmgren, J.; Czerkinsky, C. 1994: Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proceedings of the National Academy of Sciences of the United States of America 91(23): 10795-10799
Lian, T.; Ho, R.J. 1997: Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells. Pharmaceutical Research 14(10): 1309-1315
Kimura, I.; Islam, M.A.; Kimura, M. 1995: Cholera toxin accentuates the antagonism by acetylcholine of higenamine-induced positive chronotropy is isolated right atria of mice. Biological and Pharmaceutical Bulletin 18(11): 1509-1512
Bowen, J.C.; Nair, S.K.; Reddy, R.; Rouse, B.T. 1994: Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology 81(3): 338-342
Hörnquist, E.; Lycke, N. 1993: Cholera toxin adjuvant greatly promotes antigen priming of T cells. European Journal of Immunology 23(9): 2136-2143
Klimpel, G.R.; Asuncion, M.; Haithcoat, J.; Niesel, D.W. 1995: Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infection and Immunity 63(3): 1134-1137
Holmgren, J.; Lycke, N.; Czerkinsky, C. 1993: Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11(12): 1179-1184
Barnes, S.J.; Conn, P.M. 1993: Cholera toxin and dibutyryl cyclic adenosine 3',5'-monophosphate sensitize gonadotropin-releasing hormone-stimulated inositol phosphate production to inhibition in protein kinase-C (PKC)-depleted cells: evidence for cross-talk between a cholera toxin-sensitive G-protein and PKC. Endocrinology 133(6): 2756-2760
Hawes, B.E.; Barnes, S.; Conn, P.M. 1993: Cholera toxin and pertussis toxin provoke differential effects on luteinizing hormone release, inositol phosphate production, and gonadotropin-releasing hormone (GnRH) receptor binding in the gonadotrope: evidence for multiple guanyl nucleotide binding proteins in GnRH action. Endocrinology 132(5): 2124-2130
Massi, P.; Rubino, T.; Parenti, M.; Giagnoni, G.; Groppetti, A.; Parolaro, D. 1993: Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism. European Journal of Pharmacology 243(1): 65-71
Dufay, N.; Belin, M.F.; Confavreux, C.; Touraine-Moulin, F.; Derrington, E.A. 1994: Cholera toxin beta subunit induces the differentiation of human medulloblastoma cell line DEV in a neuronal pathway. European Journal of Neuroscience 6(10): 1633-1640
Kuziemko, G.M.; Stroh, M.; Stevens, R.C. 1996: Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. Biochemistry 35(20): 6375-6384
Shindler, K.S.; Roth, K.A. 1996: Cholera toxin binds to differentiating neurons in the developing murine basal ganglia. Brain Research. Developmental Brain Research 92(2): 199-210
Zhang, J.; Van Meel, J.C.; Pfaffendorf, M.; Van Zwieten, P.A. 1993: Cholera toxin but not pertussis toxin inhibits angiotensin II-enhanced contractions in the rat portal vein. European Journal of Pharmacology 230(1): 95-97
Nishikawa, T.; Yoshida, A.; Omura, M.; Sasano, H.; Noda, M. 1994: Cholera toxin can ADP-ribosylate Gs as well as Gi in ACTH-unresponsive human adrenocortical cancer. Endocrine Journal 41(5): 593-597
Müller-Wieland, D.; Krone, W. 1992: Cholera toxin diminishes tyrosine kinase activity of the insulin receptor. Biochemistry International 28(1): 161-168
Basilico, L.; Parenti, M.; Fumagalli, A.; Parolaro, D.; Giagnoni, G. 1997: Cholera toxin effects on body temperature changes induced by morphine. Pharmacology Biochemistry and Behavior 56(3): 499-505
Bromander, A.K.; Kjerrulf, M.; Holmgren, J.; Lycke, N. 1993: Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scandinavian Journal of Immunology 37(4): 452-458
Hasan, J.A.; Chowdhury, M.A.; Shahabuddin, M.; Huq, A.; Loomis, L.; Colwell, R.R. 1994: Cholera toxin gene polymerase chain reaction for detection of non-culturable Vibrio cholerae O1. World Journal of Microbiology and Biotechnology 10(5): 568-571
Leal-Berumen, I.; Snider, D.P.; Barajas-Lopez, C.; Marshall, J.S. 1996: Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells. Journal of Immunology 156(1): 316-321
Peterson, J.W.; Saini, S.S.; Dickey, W.D.; Klimpel, G.R.; Bomalaski, J.S.; Clark, M.A.; Xu, X.J.; Chopra, A.K. 1996: Cholera toxin induces synthesis of phospholipase A2-activating protein. Infection and Immunity 64(6): 2137-2143
Haack, B.M.; Emmrich, F.; Resch, K. 1993: Cholera toxin inhibits T cell receptor signaling by covalent modification of the CD3-zeta subunit. Journal of Immunology 150(7): 2599-2606
Watanabe, M.; Kiyohara, T.; Murata, K.; Yodoi, J.; Itakura, H. 1993: Cholera toxin inhibits lethal hit stage of natural killer cell-mediated cytotoxicity. Microbiology and Immunology 37(4): 317-323
Smyth, M.J.; Runnels, B.; Wharton, W. 1992: Cholera toxin potentiates TPA-induced mitogenesis and c-fos expression in BALB/c-3T3-derived proadipocytes. Journal of Cellular Biochemistry 50(2): 210-218
Lycke, N.Y. 1993: Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. Journal of Immunology 150(11): 4810-4821
Bhattacharya, M.K.; Rabbani, G.H.; Mazumder, R.N.; Khan, M.A.; Hossain, M.; Fuchs, G.J.; Mahalanabis, D. 1997: Cholera toxin stimulates glucose absorption from rabbit intestine. Indian Journal of Physiology and Allied Sciences 51(1): 35-39
Papadimitriou, E.; Mintzas, A.; Skoutari, M.; Dimitracopoulos, G.; Anastassiou, E.D. 1997: Cholera toxin stimulates human B-cell DR antigen biosynthesis at the level of translation. Cellular Immunology 180(2): 176-184
Allam, M.; Bertrand, R.; Zhang-Sun, G.; Pappas, J.; Viallet, J. 1997: Cholera toxin triggers apoptosis in human lung cancer cell lines. Cancer Research 57(13): 2615-2618
Nocerino, A.; Iafusco, M.; Guandalini, S. 1995: Cholera toxin-induced small intestinal secretion has a secretory effect on the colon of the rat. Gastroenterology 108(1): 34-39
Jiang, M.M.; Kirchgessner, A.; Gershon, M.D.; Surprenant, A. 1993: Cholera toxin-sensitive neurons in guinea pig submucosal plexus. American Journal of Physiology 264(1 Pt 1): G86-G94
Aye-Kyaw; Win, K.T.; Oo, L.L.; Oo, T. 1993: Cholera toxin: radio-iodination and uptake by the intestine of sucking rats. Comparative Biochemistry and Physiology. C Comparative Pharmacology and Toxicology 105(3): 397-400
Lacey, S.W. 1995: Cholera: calamitous past, ominous future. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 20(5): 1409-1419
Martino, Olindo, A.L. 1992: Cholera: Current status. Prensa Medica Argentina 79(6): 330-333
van Loon, F.P. 1993: Cholera: developments in prevention and cure. Tropical and Geographical Medicine 45(6): 269-273
Estrada-García, T.; Mintz, E.D. 1996: Cholera: Foodborne transmission and its prevention. European Journal of Epidemiology 12(5): 461-469
Raeber, Pierre-Alain 1996: Cholera: Is it a danger for our alimentation?. Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene 87(1): 48-54
Waiyaki, P.G. 1996: Cholera: its story in Africa with special reference to Kenya and other east African countries. East African Medical Journal 73(1): 40-43
Toyoshige, M.; Okuya, S.; Rebois, R.V. 1994: Choleragen catalyzes ADP-ribosylation of the stimulatory G protein heterotrimer but not its free alpha-subunit. Biochemistry 33(16): 4865-4871
Siegers, C.P.; Deters, M.; Strubelt, O.; Haensel, W. 1997: Choleretic properties of different curcuminoids in the rat bile-fistula model. Pharmaceutical and Pharmacological Letters 7(2-3): 87-89
Grimaldi, C.; Darcourt, J.; Harris, A.G.; Lebot, E.; Lapalus, F.; Delmont, J. 1993: Cholescintigraphic study of effect of somatostatin analog, octreotide, on bile secretion and gallbladder emptying in normal subjects. Digestive Diseases and Sciences 38(9): 1718-1721
Kim, C.K.; Tse, K.K.; Juweid, M.; Mozley, P.D.; Woda, A.; Alavi, A. 1993: Cholescintigraphy in the diagnosis of acute cholecystitis: morphine augmentation is superior to delayed imaging. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 34(11): 1866-1870
Hahn, M.; Tang, M.; Subbiah, M.T. 1995: Cholest-3,5-dien-7-one formation in peroxidized human plasma as an indicator of lipoprotein cholesterol peroxidation potential. Biochimica Et Biophysica Acta 1255(3): 341-343
Mimaki, Y.; Kuroda, M.; Kameyama, A.; Sashida, Y.; Hirano, T.; Oka, K.; Maekawa, R.; Wada, T.; Sugita, K.; Beutler, J.A. 1997: Cholestane glycosides with potent cytostatic activities on various tumor cells from Ornithogalum saundersiae bulbs. Bioorganic and Medicinal Chemistry Letters 7(5): 633-636
Sanchez-Campos, S.; Lopez-Acebo, R.; Gonzalez, P.; Culebras, J.M.; Tuñon, M.J.; Gonzalez-Gallego, J. 1998: Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. Transplantation 66(1): 84-88
Choo-Kang, L.R.; Sun, C.C.; Counts, D.R. 1996: Cholestasis and hypoglycemia: manifestations of congenital anterior hypopituitarism. Journal of Clinical Endocrinology and Metabolism 81(8): 2786-2789
Acevedo, C.; Bengochea, L.; Tchercansky, D.M.; Ouviña, G.; Perazzo, J.C.; Lago, N.; Lemberg, A.; Rubio, M.C. 1995: Cholestasis as a liver protective factor in paracetamol acute overdose. General Pharmacology 26(7): 1619-1624
Wulf, H.; Leger, R.; Raetzell, M.; Olmer, A.; Scheiderer, U. 1998: Cholestasis as a side effect of bupivacaine?. Regional Anesthesia and Pain Medicine 23(3): 278-282
Matyushin, B.N.; Loginov, A.S.; Yakimchuk, G.N. 1992: Cholestasis assessment from the superoxide dismutase/ceruloplasmin ratio in hepatobiliary diseases. Klinicheskaya Laboratornaya Diagnostika 1992(9-10): 11-13
Stoschus, B.; Meybehm, M.; Spengler, U.; Scheurlen, C.; Sauerbruch, T. 1997: Cholestasis associated with mesalazine therapy in a patient with Crohn's disease. Journal of Hepatology 26(2): 425-428
Böhme, M.; Müller, M.; Leier, I.; Jedlitschky, G.; Keppler, D. 1994: Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 107(1): 255-265
Lieser, M.J.; Park, J.; Natori, S.; Jones, B.A.; Bronk, S.F.; Gores, G.J. 1998: Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology 115(3): 693-701
Vajro, P.; Amelio, A.; Stagni, A.; Paludetto, R.; Genovese, E.; Giuffré, M.; DeCurtis, M. 1997: Cholestasis in newborn infants with perinatal asphyxia. Acta Paediatrica 86(8): 895-898
Bergasa, N.V.; Alling, D.W.; Vergalla, J.; Jones, E.A. 1994: Cholestasis in the male rat is associated with naloxone-reversible antinociception. Journal of Hepatology 20(1): 85-90
Lersch, C.; Seige, M.; Natrath, W.; Heidecke, W.; Wittekind, C.; Classen, M.; Schepp, W. 1995: Cholestasis induced hyperthyroidism after liver transplantation. Digestion 56(5): 429-432
Bergasa, N.V.; Sabol, S.L.; Young, W.S.; Kleiner, D.E.; Jones, E.A. 1995: Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. American Journal of Physiology 268(2 Pt 1): G346-G354
Landmann, L. 1995: Cholestasis-induced alterations of the trans- and paracellular pathways in rat hepatocytes. Histochemistry and Cell Biology 103(1): 3-9
Chan, F.K.; Shaffer, E.A. 1997: Cholestatic effects of cyclosporine in the rat. Transplantation 63(11): 1574-1578
Derby, L.E.; Jick, H.; Henry, D.A.; Dean, A.D. 1993: Cholestatic hepatitis associated with flucloxacillin. Medical Journal of Australia 158(9): 596-600
Persaud, D.; Bangaru, B.; Greco, M.A.; Nachman, S.; Mittal, K.; Chandwani, S.; Krasinski, K.; Borkowsky, W.; Kaul, A. 1993: Cholestatic hepatitis in children infected with the human immunodeficiency virus. Pediatric Infectious Disease Journal 12(6): 492-498
Lim, H.L.; Lau, G.K.; Davis, G.L.; Dolson, D.J.; Lau, J.Y. 1994: Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 106(1): 248-251
Ellaway, C.J.; Silinik, M.; Cowell, C.T.; Gaskin, K.J.; Kamath, K.R.; Dorney, S.; Donaghue, K.C. 1995: Cholestatic jaundice and congenital hypopituitarism. Journal of Paediatrics and Child Health 31(1): 51-53
Pereira-Lima, J.C.; Krömer, M.U.; Adamek, H.E.; Riemann, J.F. 1996: Cholestatic jaundice due to Ormond's disease (primary retroperitoneal fibrosis). Hepato-Gastroenterology 43(10): 992-994
Labowitz, J.K.; Silverman, W.B. 1997: Cholestatic jaundice induced by ciprofloxacin. Digestive Diseases and Sciences 42(1): 192-194
Altraif, I.; Lilly, L.; Wanless, I.R.; Heathcote, J. 1994: Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. American Journal of Gastroenterology 89(8): 1230-1234
van de Meeberg, P.C.; Wolfhagen, F.H.; van Erpecum, K.J.; van Berge Henegouwen, G.P. 1995: Cholestatic liver diseases: New strategies for prevention and treatment of hepatobiliary and cholestatic diseases. Netherlands Journal of Medicine 47(1): 30-35
Neuschwander-Tetri, B.A.; Nicholson, C.; Wells, L.D.; Tracy, T.F. 1996: Cholestatic liver injury down-regulates hepatic glutathione synthesis. Journal of Surgical Research 63(2): 447-451
Lechner, A.J.; Velasquez, A.; Knudsen, K.R.; Johanns, C.A.; Tracy, T.F.; Matuschak, G.M. 1998: Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. American Journal of Respiratory and Critical Care Medicine 157(5 Part 1): 1550-1558
Schwoerer, H.; Ramadori, G. 1995: Cholestatic pruritus - Pathophysiology and therapy with special concern on its treatment with 5-hydroxytryptamine subtype-3 receptor antagonists. Zeitschrift fuer Gastroenterologie 33(5): 265-274
Rosenthal, E.; Diamond, E.; Benderly, A.; Etzioni, A. 1994: Cholestatic pruritus: effect of phototherapy on pruritus and excretion of bile acids in urine. Acta Paediatrica 83(8): 888-891
Corpechot, C.; Cadranel, J.F.; Hoang, C.; Assogba, U.; Beaumont, J.L.; Rogeaux, O.; Lunel, F.; Opolon, P. 1994: Cholestatic viral hepatitis A in adults. Clinical, biological and histopathological study of 9 cases. Gastroenterologie Clinique et Biologique 18(8-9): 743-750
Benis, N.; Noussios, G.; Philippidis, C.; Xanthopoulos, J.; Kontzoglou, G.; Liatsis, J.; Preponis, C. 1994: Cholesteatoma bacteria flora. Deltion Ellinikis Mikrobiologikis Etaireias 39(5): 482-487
Elrashidi, A.M. 1992: Cholesteatoma in children. An Egyptian overview. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 249(7): 389-392
Quaranta, A.; Bartoli, R.; Lozupone, E.; Resta, L.; Iurato, S. 1995: Cholesteatoma in children: histopathologic findings in middle ear ossicles. Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties 57(5): 296-298
Palva, T. 1993: Cholesteatoma surgery today. Clinical Otolaryngology and Allied Sciences 18(4): 245-252
Wennmo, C.; Petersen, H.; Flisberg, K. 1996: Cholesteatoma surgery with the canal-wall-down technique. Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties 58(1): 39-41
Karmarkar, S.; Bhatia, S.; Saleh, E.; DeDonato, G.; Taibah, A.; Russo, A.; Sanna, M. 1995: Cholesteatoma surgery: the individualized technique. Annals of Otology Rhinology and Laryngology 104(8): 591-595
Suzuki, M. 1997: Cholesteatoma with labyrinthine fistula and spontaneous nystagmus. Jibi Inkoka Tokeibu Geka 69(7): 464-468
Albino, A.P.; Kimmelman, C.P.; Parisier, S.C. 1998: Cholesteatoma: a molecular and cellular puzzle. American Journal of Otology 19(1): 7-19
Garber, L.Z.; Dort, J.C. 1994: Cholesteatoma: diagnosis and staging by CT scan. Journal of Otolaryngology 23(2): 121-124
Sadé, J.; Fuchs, C. 1994: Cholesteatoma: ossicular destruction in adults and children. Journal of Laryngology and Otology 108(7): 541-544
Vian, B.; Reis, D.; Darzens, D.; Roland, J.C. 1994: Cholesteric-like crystal analogs in glucuronoxylan-rich cell wall composites: Experimental approach of acellular re-assembly from native cellulosic suspension. Protoplasma 180(1-2): 70-81
Maeda, N.; Iwasaki, A.; Mori, Y.; Ikoma, F. 1993: Cholesterin granuloma in a hemodialysis patient with polycystic kidney disease. Hinyokika Kiyo. Acta Urologica Japonica 39(6): 557-559
Somanchi, M.; Ghosh, P.; Redman, R.S.; Lakshman, M.R. 1997: Cholesterogenesis, lipogenesis, cholesterol degradation to bile acids, and histopathology of the liver in LA/N-cp obese rats. Hepatology 25(6): 1451-1456
Dueland, S.; France, D.; Wang, S.L.; Trawick, J.D.; Davis, R.A. 1997: Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells. Journal of Lipid Research 38(7): 1445-1453
Massimi, M.; Lear, S.R.; Huling, S.L.; Jones, A.L.; Erickson, S.K. 1998: Cholesterol 7alpha-hydroxylase (CYP7A): patterns of messenger RNA expression during rat liver development. Hepatology 28(4): 1064-1072
Myers-Payne, S.C.; Hui, D.Y.; Brockman, H.L.; Schroeder, F. 1995: Cholesterol Esterase: A Cholesterol Transfer Protein. Biochemistry 34(12): 3942-3947
Portincasa, P.; Stolk, M.F.; van Erpecum, K.J.; Palasciano, G.; van Berge-Henegouwen, G.P. 1995: Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect. Scandinavian Journal of Gastroenterology. Supplement 212: 63-78
Soons, K.R.; Little, D.N.; Harvey, J. 1995: Cholesterol screening in the elderly: changing attitudes. Gerontology 41(1): 57-62
Gylling, H.; Miettinen, T.A. 1994: Cholesterol absorption and cholesterol and bile acid synthesis in two brothers with IDDM and diarrhea. Diabetes Care 17(11): 1345-1347
Gylling, H.; Miettinen, T.A. 1996: Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus with and without coronary artery disease. Atherosclerosis 126(2): 325-332
Gylling, H.; Kontula, K.; Miettinen, T.A. 1995: Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes. Arteriosclerosis Thrombosis and Vascular Biology 15(2): 208-213
Miettinen, T.A.; Gylling, H.; Vanhanen, H.; Ollus, A. 1992: Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 12(9): 1044-1052
Gaynor, P.M.; Zhang, W.Y.; Salehizadeh, B.; Pettiford, B.; Kruth, H.S. 1996: Cholesterol accumulation in human cornea: evidence that extracellular cholesteryl ester-rich lipid particles deposit independently of foam cells. Journal of Lipid Research 37(9): 1849-1861
Crockett, E., L.; Hazel, J., R. 1997: Cholesterol affects physical properties and (Na+,K+)-ATPase in basolateral membranes of renal and intestinal epithelia from thermally acclimated rainbow trout. Journal of Comparative Physiology B Biochemical Systemic and Environmental Physiology 167(5): 344-351
LaRosa, J.C. 1996: Cholesterol agonistics. Annals of Internal Medicine 124(5): 505-508
Klatt, L., V.; Mitchell, B., A.; Smith, R., L. 1995: Cholesterol analysis in foods by direct saponification-gas chromatographic method: Collaborative study. Journal - Association of Official Analytical Chemists 78(1): 75-79
Fornas, E.; Renau-Piqueras, J.; Fortea, A.; Mayordomo, F.; Alborch, E. 1993: Cholesterol and 25-hydroxycholesterol retention in specimens of liver and aorta prepared for electron microscopy. I. Standard fixation methods and metabolism of the labeled sterols. Lipids 28(10): 923-928
Fornas, E.; Renau-Piqueras, J.; Fortea, A.; Mayordomo, F.; Alborch, E. 1993: Cholesterol and 25-hydroxycholesterol retention in specimens of liver and aorta prepared for electron microscopy. II. Effect of filipin, osmium, digitonin and saponin. Lipids 28(10): 929-935
Paraskevopoulou, A.; Kiosseoglou, V. 1994: Cholesterol and Other Lipid Extraction from Egg Yolk Using Organic Solvents: Effects on Functional Properties of Yolk. Journal of Food Science 59(4): 766-768
Kashyap, M.L. 1997: Cholesterol and atherosclerosis: a contemporary perspective. Annals of the Academy of Medicine Singapore 26(4): 517-523
Férézou, J.; Beau, P.; Parquet, M.; Champarnaud, G.; Lutton, C.; Matuchansky, C. 1993: Cholesterol and bile acid biodynamics after total small bowel resection and bile diversion in humans. Gastroenterology 104(6): 1786-1795
Makino, I.; Chijiiwa, K.; Fukushima, K.; Kameoka, N.; Komura, M.; Kuroki, S.; Yamashita, H.; Tanaka, M. 1997: Cholesterol and bile acid metabolism after selective portal vein ligation. Journal of Surgical Research 68(2): 91-98
Nwokoro, N.A.; Mulvihill, J.J. 1997: Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome. American Journal of Medical Genetics 68(3): 315-321
Barter, P. 1994: Cholesterol and cardiovascular disease: Basic science. Australian and New Zealand Journal of Medicine 24(1): 83-88
Rostand, K.S.; Esko, J.D. 1993: Cholesterol and cholesterol esters: host receptors for Pseudomonas aeruginosa adherence. Journal of Biological Chemistry 268(32): 24053-24059
Jacobsen, S.J.; Freedman, D.S.; Hoffmann, R.G.; Gruchow, H.W.; Anderson, A.J.; Barboriak, J.J. 1992: Cholesterol and coronary artery disease: age as an effect modifier. Journal of Clinical Epidemiology 45(10): 1053-1059
Kinosian, B.; Glick, H.; Garland, G. 1994: Cholesterol and coronary heart disease: predicting risks by levels and ratios. Annals of Internal Medicine 121(9): 641-647
Kinosian, B.; Glick, H.; Preiss, L.; Puder, K.L. 1995: Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 43(5): 443-450
Grundy, S.M. 1997: Cholesterol and coronary heart disease. The 21st century. Archives of Internal Medicine 157(11): 1177-1184
Liu, F.; Sugar, I.P.; Chong, P.L. 1997: Cholesterol and ergosterol superlattices in three-component liquid crystalline lipid bilayers as revealed by dehydroergosterol fluorescence. Biophysical Journal 72(5): 2243-2254
Sieber, R.; Rose-Sallin, C.; Bosset, J.-Olivier 1997: Cholesterol and its oxidation products in dairy products: Analysis, effect of technological treatment, nutritional consequences. Sciences des Aliments 17(3): 243-252
Meyer, H.W.; Rettig, W. 1997: Cholesterol and lanosterol induced convex-concave curvatures in gel-state phospholipid bilayers. Pharmazie 52(9): 706-709
Sullivan, D. 1994: Cholesterol and non-cardiovascular disease: Basic science. Australian and New Zealand Journal of Medicine 24(1): 92-97
Laurier, D.; Chau, N.P.; Segond, P. 1992: Cholesterol and other cardiovascular risk factors in a working population in ILe-De-France (France): First results of the PCV-METRA study. European Journal of Epidemiology 8(5): 693-701
den Hartigh, J.C.; van Bergen en Henegouwen, P.M.; Boonstra, J.; Verkleij, A.J. 1993: Cholesterol and phosphoinositides increase affinity of the epidermal growth factor receptor. Biochimica et Biophysica Acta 1148(2): 249-256
Tanphaichitr, N.; Zheng, Y.S.; Kates, M.; Abdullah, N.; Chan, A. 1996: Cholesterol and phospholipid levels of washed and percoll gradient centrifuged mouse sperm: presence of lipids possessing inhibitory effects on sperm motility. Molecular Reproduction and Development 43(2): 187-195
Diaz-Fontdevila, M.; Bustos-Obregón, E. 1993: Cholesterol and polyunsaturated acid enriched diet: effect on kinetics of the acrosome reaction in rabbit spermatozoa. Molecular Reproduction and Development 35(2): 176-180
Wardle, J. 1995: Cholesterol and psychological well-being. Journal of Psychosomatic Research 39(5): 549-562
Pfeffer, M.A.; Sacks, F.M.; Moyé, L.A.; Brown, L.; Rouleau, J.L.; Hartley, L.H.; Rouleau, J.; Grimm, R.; Sestier, F.; Wickemeyer, W. 1995: Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. American Journal of Cardiology 76(9): 98C
Schroeder, R.J.; Ahmed, S.N.; Zhu, Y.; London, E.; Brown, D.A. 1998: Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains. Journal of Biological Chemistry 273(2): 1150-1157
Chen, H.; Born, E.; Mathur, S.N.; Field, F.J. 1993: Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content. Journal of Lipid Research 34(12): 2159-2167
Kaiser, F.E. 1993: Cholesterol and the older adult. Southern Medical Journal 86(10): 2s11-2s14
Golomb, B.A. 1998: Cholesterol and violence: is there a connection?. Annals of Internal Medicine 128(6): 478-487
Gimpl, G.; Burger, K.; Fahrenholz, F. 1997: Cholesterol as modulator of receptor function. Biochemistry 36(36): 10959-10974
Silvius, J.R.; del Giudice, D.; Lafleur, M. 1996: Cholesterol at different bilayer concentrations can promote or antagonize lateral segregation of phospholipids of differing acyl chain length. Biochemistry 35(48): 15198-15208
Scolari, F.; Bracchi, M.; Valzorio, B.; Movilli, E.; Costantino, E.; Savoldi, S.; Zorat, S.; Bonardelli, S.; Tardanico, R.; Maiorca, R. 1996: Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 11(8): 1607-1612
Rankin, S.A.; Pike, O.A. 1993: Cholesterol autoxidation inhibition varies among several natural antioxidants in an aqueous model system. Journal of Food Science 58(3): 653-655, 687
Murdoch, M.; Wilt, T.J. 1997: Cholesterol awareness after case-finding: do patients really know their cholesterol numbers?. American Journal of Preventive Medicine 13(4): 284-289
Lenz, M.; Miehe, W.P.; Vahrenwald, F.; Bruchelt, G.; Schweizer, P.; Girgert, R. 1997: Cholesterol based antineoplastic strategies. Anticancer Research 17(2a): 1143-1146
Lee, J.N.; Paik, Y.K. 1997: Cholesterol biosynthesis from lanosterol: Development of a novel assay method, characterization, and solubilization of rat hepatic microsomal sterol DELTA7-reductase. Journal of Biochemistry and Molecular Biology 30(5): 370-377
Kim, C.K.; Jeon, K.I.; Lim, D.M.; Johng, T.N.; Trzaskos, J.M.; Gaylor, J.L.; Paik, Y.K. 1995: Cholesterol biosynthesis from lanosterol: regulation and purification of rat hepatic sterol 14-reductase. Biochimica et Biophysica Acta 1259(1): 39-48
Kang, M.K.; Kim, C.K.; Johng, T.N.; Paik, Y.K. 1995: Cholesterol biosynthesis from lanosterol: regulation and purification of rat hepatic sterol 8-isomerase. Journal of Biochemistry 117(4): 819-823
Wanders, R.J.; Romeijn, G.J. 1996: Cholesterol biosynthesis in Zellweger syndrome: Normal activity of mevalonate kinase, mevalonate-5'-pyrophosphate decarboxylase and IPP-isomerase in patients' fibroblasts but deficient mevalonate kinase activity in liver. Journal of Inherited Metabolic Disease 19(2): 193-196
Malle, E.; Oettl, K.; Sattler, W.; Hoefler, G.; Kostner, G.M. 1995: Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin. European Journal of Clinical Investigation 25(1): 59-67
Kolf-Clauw, M.; Chevy, F.; Siliart, B.; Wolf, C.; Mulliez, N.; Roux, C. 1997: Cholesterol biosynthesis inhibited by BM15.766 induces holoprosencephaly in the rat. Teratology 56(3): 188-200
Wanders, R.J.; Romeijn, G.J. 1998: Cholesterol biosynthesis, peroxisomes and peroxisomal disorders: Mevalonate kinase is not only deficient in Zellweger syndrome but also in rhizomelic chondrodysplasia punctata. Journal of Inherited Metabolic Disease 21(3): 309-312
Gong-Bingyong, C.-Ruiying; Jiang-Jian; Zhu-Baoquan 1996: Cholesterol biosynthetic inhibitor from microorganisms. III. Studies on transformation product of antibiotic SIPI-8915. Zhongguo Kangshengsu Zazhi 21(4): 241-248
Shu, O.; Zhu, B.-Quan; Gong, B.-Yong 1993: Cholesterol biosynthetic inhibitor: Studies on antibiotic SIPI-89-17-III. Chinese Journal of Antibiotics 18(2): 128-135
Cohen, D.E.; Kaler, E.W.; Carey, M.C. 1993: Cholesterol carriers in human bile: are "lamellae" involved?. Hepatology 18(6): 1522-1531
Lasa, M.; Perez-Caballero, F.J.; Usera, F.; Chiloeches, A.; Montes, A.; Toro, M.J. 1993: Cholesterol cell content affects prolactin but not growth hormone release in GH4C1 cells. Endocrinology 132(4): 1701-1706
Allen, S.S.; Hatsukami, D.; Gorsline, J.; Group, T.T.ansdermal Nicotine Study 1994: Cholesterol changes in smoking cessation using the transdermal nicotine system. Preventive Medicine 23(2): 196
Heinecke, J.W.; Li, W.; Mueller, D.M.; Bohrer, A.; Turk, J. 1994: Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: Potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry 33(33): 10127-10136
Afdhal, N.H.; Gong, D.; Niu, N.; Turner, B.; LaMont, J.T.; Offner, G.D. 1993: Cholesterol cholelithiasis in the prairie dog: Role of mucin and nonmucin glycoproteins. Hepatology 17(4): 693-700
Ahaneku, J.E.; Dioka, C.E.; Ndefo, J. 1996: Cholesterol concentrations in diabetic patients in Nnewi, Nigeria. European Journal of Clinical Chemistry and Clinical Biochemistry: Journal of the Forum of European Clinical Chemistry Societies 34(4): 339-341
Stillwell, W.; Ehringer, W.D.; Dumaual, A.C.; Wassall, S.R. 1994: Cholesterol condensation of alpha-linolenic and gamma-linolenic acid-containing phosphatidylcholine monolayers and bilayers. Biochimica et Biophysica Acta 1214(2): 131-136
Opie, L.H. 1993: Cholesterol confusion in primary prevention of coronary artery disease. Cardiovascular Drugs and Therapy 7(5): 779-784
Dyer Hurdon, J.N.; Nnanna, I.A. 1993: Cholesterol content and functionality of plasma and granules fractionated from egg yolk. Journal of Food Science 58(6): 1277-1281
Zakharova, T.S.; Ivanov, A.S.; Echkalov, A.P.; Berezov, A.T.; Khalilov, E.M.; Archakov, A.I. 1994: Cholesterol content in liposomes regulates their interaction with blood serum lipoproteins. Biokhimiya 59(5): 712-719
Dessì, S.; Batetta, B.; Pulisci, D.; Spano, O.; Anchisi, C.; Tessitore, L.; Costelli, P.; Baccino, F.M.; Aroasio, E.; Pani, P. 1994: Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73(2): 253-258
Bragagnolo, N.; Rodriguez Amaya, D.B. 1993: Cholesterol content of chicken meat. Revista de Farmacia e Bioquimica da Universidade de Sao Paulo 28(2): 122-131
Lecomte, E.; Herbeth, B.; Clerc, G.; Khalife, K.; Siest, G.; Artur, Y. 1995: Cholesterol content of circulating immune complexes in patients with coronary stenosis and subjects without evidence of atherosclerosis. Clinical Chemistry 41(10): 1526-1531
De Vries, A.C.; Vermeer, M.A.; Bredman, J.J.; Bär, P.R.; Cohen, L.H. 1993: Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin. Experimental Eye Research 56(4): 393-399
Robertson, J.C.; Hazel, J.R. 1995: Cholesterol content of trout plasma membranes varies with acclimation temperature. American Journal of Physiology 269(5 Part 2): R1113-R1119
Moolenaar, W.; Lamers, C.B. 1996: Cholesterol crystal embolisation to the alimentary tract. Gut 38(2): 196-200
Moolenaar, W.; Lamers, C.B. 1996: Cholesterol crystal embolization to liver, gallbladder, and pancreas. Digestive Diseases and Sciences 41(9): 1819-1822
Portincasa, P.; van Erpecum, K.J.; Vanberge-Henegouwen, G.P. 1997: Cholesterol crystallisation in bile. Gut 41(2): 138-141
Van Erpecum, K.J.; Van Berge-henegouwen, G.P.; Eckhardt, E.R.; Portincasa, P.; Van De Heijning, B.J.; Dallinga-Thie, G.M.; Groen, A.K. 1998: Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform. Hepatology 27(6): 1508-1516
Nair, P.N.; Sjögren, U.; Sundqvist, G. 1998: Cholesterol crystals as an etiological factor in non-resolving chronic inflammation: An experimental study in guinea pigs. European Journal of Oral Sciences 106(2 Pt 1): 644-650
Kiyak, J.H. 1997: Cholesterol crystals, smooth muscle cells and new data on the genesis of atherosclerosis. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 48(1): 49-55
Pike, L.J.; Miller, J.M. 1998: Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. Journal of Biological Chemistry 273(35): 22298-22304
Simons, M.; Keller, P.; De Strooper, B.; Beyreuther, K.; Dotti, C.G.; Simons, K. 1998: Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 95(11): 6460-6464
Furuchi, T.; Anderson, R.G. 1998: Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). Journal of Biological Chemistry 273(33): 21099-21104
Greenspan, P.; Yu, H.; Mao, F.; Gutman, R.L. 1997: Cholesterol deposition in macrophages: foam cell formation mediated by cholesterol-enriched oxidized low density lipoprotein. Journal of Lipid Research 38(1): 101-109
Martin, O.C.; Comly, M.E.; Blanchette-Mackie, E.J.; Pentchev, P.G.; Pagano, R.E. 1993: Cholesterol deprivation affects the fluorescence properties of a ceramide analog at the Golgi apparatus of living cells. Proceedings of the National Academy of Sciences of the United States of America 90(7): 2661-2665
Biessen, E.A.; Vietsch, H.; Van Berkel, T.J. 1994: Cholesterol derivative of a new triantennary cluster galactoside directs low- and high-density lipoproteins to the parenchymal liver cell. Biochemical Journal 302: 283-289
Biessen, E.A.; Vietsch, H.; Van Berkel, T.J. 1995: Cholesterol derivative of a new triantennary cluster galactoside lowers serum cholesterol levels and enhances secretion of bile acids in the rat. Circulation 91(6): 1847-1854
Ishiwata, H.; Sato, S.B.; Vertut-Doï, A.; Hamashima, Y.; Miyajima, K. 1997: Cholesterol derivative of poly(ethylene glycol) inhibits clathrin-independent, but not clathrin-dependent endocytosis. Biochimica et Biophysica Acta 1359(2): 123-135
Akcasu, A.; Kaleagasioglu, F.; Baykut, F. 1995: Cholesterol dichloride: I. Hypolipidemic effect. Cerrahpasa Tip Dergisi 26(2): 94-97
Mukherjee, S.; Zha, X.; Tabas, I.; Maxfield, F.R. 1998: Cholesterol distribution in living cells: fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog. Biophysical Journal 75(4): 1915-1925
Shmeeda, H.; Petkova, D.; Barenholz, Y. 1995: Cholesterol distribution in rat heart myocytes. American Journal of Physiology 268(2 Pt 2): H759-H766
El Yandouzi, E.H.; Zlatkine, P.; Moll, G.; Le Grimellec, C. 1994: Cholesterol distribution in renal epithelial cells LLC-PK1 as determined by cholesterol oxidase: evidence that glutaraldehyde fixation masks plasma membrane cholesterol pools. Biochemistry 33(8): 2329-2334
Vélez, M.; Lillo, M.P.; Acuña, A.U.; González-Rodríguez, J. 1995: Cholesterol effect on the physical state of lipid multibilayers from the platelet plasma membrane by time-resolved fluorescence. Biochimica Et Biophysica Acta 1235(2): 343-350
Nouri-Sorkhabi, M.H.; Chapman, B.E.; Sullivan, D.R.; Kuchel, P.W. 1994: Cholesterol effects on nonelectrolyte membrane transport in human erythrocytes: NMR magnetization transfer studies. Magnetic Resonance in Medicine 32(4): 505-510
Ueyama, K.; Yokode, M.; Arai, H.; Nagano, Y.; Li, Z.X.; Cho, M.; Kita, T. 1998: Cholesterol efflux effect of high density lipoprotein is impaired by whole cigarette smoke extracts through lipid peroxidation. Free Radical Biology and Medicine 24(1): 182-190
Syvänne, M.; Castro, G.; Dengremont, C.; De Geitere, C.; Jauhiainen, M.; Ehnholm, C.; Michelagnoli, S.; Franceschini, G.; Kahri, J.; Taskinen, M.R. 1996: Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: Importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis 127(2): 245-253
Agnani, G.; Marcel, Y.L. 1993: Cholesterol efflux from fibroblasts to discoidal lipoproteins with apolipoprotein A-I (LpA-I) increases with particle size but cholesterol transfer from LpA-I to lipoproteins decreases with size. Biochemistry 32(10): 2643-2649
Skarlatos, S.I.; Duverger, N.; Rader, D.; Kruth, H.S. 1995: Cholesterol efflux from human monocyte-derived macrophages in the presence of LpA-I:A-II. Biochimica et Biophysica Acta 1270(1): 19-25
Stein, O.; Dabach, Y.; Hollander, G.; Ben-Naim, M.; Halperin, G.; Okon, E.; Stein, Y. 1997: Cholesterol efflux in vivo from a depot of cationized LDL injected into a thigh muscle of small rodents. Atherosclerosis 133(1): 15-22
Yancey, P.G.; St Clair, R.W. 1992: Cholesterol efflux is defective in macrophages from atherosclerosis-susceptible White Carneau pigeons relative to resistant show racer pigeons. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 12(11): 1291-1304
Mendez, A.J. 1997: Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. Journal of Lipid Research 38(9): 1807-1821
Huang, Y.; Von Eckardstein, A.; Wu, S.; Assmann, G. 1995: Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arteriosclerosis Thrombosis and Vascular Biology 15(9): 1412-1418
Castro, G.; Nihoul, L.P.; Dengremont, C.; de Geitère, C.; Delfly, B.; Tailleux, A.; Fievet, C.; Duverger, N.; Denèfle, P.; Fruchart, J.C.; Rubin, E.M. 1997: Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Biochemistry 36(8): 2243-2249
Peat, D.S.; Mathieson, P.W. 1996: Cholesterol emboli may mimic systemic vasculitis. Bmj 313(7056): 546-547
Singh, I.; Killen, P.D.; Leichtman, A.B. 1995: Cholesterol emboli presenting as acute allograft dysfunction after renal transplantation. Journal of the American Society of Nephrology: Jasn 6(2): 165-170
Banning, A.P.; Orr, W.P.; Gribbin, B. 1998: Cholesterol embolisation. Heart 79(2): 113-114
Geroulakos, G.; Homer-Vanniasinkam, S.; Wilkinson, A.; Galloway, I. 1997: Cholesterol embolisation. A lethal complication of instrumentation of an aneurysmal aorta: a case report. International Angiology: a Journal of the International Union of Angiology 16(1): 69-71
Adorati, M.; Pizzolitto, S.; Franzon, R.; Vallone, C.; Artero, M.; Moro, A. 1998: Cholesterol embolism and acute interstitial nephritis: two adverse effects of streptokinase thrombolytic therapy in the same patient. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 13(5): 1262-1264
Borrego, L.; Gil, R.; Mazuecos, A.; Ruiz, R.; López, J.L.; Iglesias, L. 1992: Cholesterol embolism to the skin. Clinical and Experimental Dermatology 17(6): 424-426
Bennett, M.J.; Nantz, M.H.; Balasubramaniam, R.P.; Gruenert, D.C.; Malone, R.W. 1995: Cholesterol enhances cationic liposome-mediated DNA transfection of human respiratory epithelial cells. Bioscience Reports 15(1): 47-53
Sachinidis, A.; Liu, M.; Weber, A.-Aron; Seul, C.; Harth, V.; Seewald, S.; Ko, Y.; Vetter, H. 1997: Cholesterol enhances platelet-derived growth factor-BB-induced (Ca-2+)-i and DNA synthesis in rat aortic smooth muscle cells. Hypertension 29(1 Part 2): 326-333
Schimmel, R.J.; Shah, P.; Fenner, M.; Boesze-Battaglia, K. 1997: Cholesterol enhances the adhesion of human platelets to fibrinogen: studies using a novel fluorescence based assay. Platelets 8(4): 261-267
Mooradian, A.D.; Lung, C.C.; Pinnas, J.L. 1995: Cholesterol enriched diet enhances malondialdehyde modification of proteins in cerebral microvessels of rabbits. Neuroscience Letters 185(3): 211-213
Kraemer, R.; Pomerantz, K.B.; Kesav, S.; Scallen, T.J.; Hajjar, D.P. 1995: Cholesterol enrichment enhances expression of sterol-carrier protein-2: implications for its function in intracellular cholesterol trafficking. Journal of Lipid Research 36(12): 2630-2638
Lau, Y.T. 1994: Cholesterol enrichment inhibits Na+/K+ pump in endothelial cells. Atherosclerosis 110(2): 251-257
Pomerantz, K.B.; Hajjar, D.P.; Levi, R.; Gross, S.S. 1993: Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis. Biochemical and Biophysical Research Communications 191(1): 103-109
Ning, G.; Fujimoto, T.; Koike, H.; Ogawa, K. 1993: Cholesterol ester in corpus luteum of rat observed by analytical color fluorescence electron microscopy. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 41(4): 617-625
Pulcini, T.; Elchebly, M.; Dusserre, E.; Berthezene, F.; Ponsin, G. 1995: Cholesterol ester transfer and high-density lipoprotein conversion in normolipidemic, hypercholesterolemic, and hypertriglyceridemic non-insulin-dependent diabetics. Biochemical and Molecular Medicine 55(1): 54-60
Nishida, H.I.; Arai, H.; Nishida, T. 1993: Cholesterol ester transfer mediated by lipid transfer protein as influenced by changes in the charge characteristics of plasma lipoproteins. Journal of Biological Chemistry 268(22): 16352-16360
Sugano, H. 1995: Cholesterol esterase in the human placenta. Nichidai Igaku Zasshi 54(1): 72-79
Graham, A.; Wood, J.L.; Russell, L.J. 1996: Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells. Biochimica Et Biophysica Acta 1302(1): 46-54
Wood, W.G.; Rao, A.M.; Igbavboa, U.; Semotuk, M. 1993: Cholesterol exchange and lateral cholesterol pools in synaptosomal membranes of pair-fed control and chronic ethanol-treated mice. Alcoholism Clinical and Experimental Research 17(2): 345-350
Jurevics, H.; Morell, P. 1995: Cholesterol for synthesis of myelin is made locally, not imported into brain. Journal of Neurochemistry 64(2): 895-901
Crockett, E.L. 1998: Cholesterol function in plasma membranes from ectotherms: Membrane-specific roles in adaptation to temperature. American Zoologist 38(2): 291-304
Erpek, G.; Ustün, H. 1994: Cholesterol granuloma in the maxillary sinus. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 251(4): 246-247
Reynolds, H.E.; Cramer, H.M. 1994: Cholesterol granuloma of the breast: a mimic of carcinoma. Radiology 191(1): 249-250
Dilek, F.H.; Kiriş, M.; Uğraş, S. 1997: Cholesterol granuloma of the maxillary sinus. A case report. Rhinology 35(3): 140-141
Kunt, T.; Ozturkcan, S.; Egilmez, R. 1998: Cholesterol granuloma of the maxillary sinus: six cases from the same region. Journal of Laryngology and Otology 112(1): 65-68
Campos, A.; Armengot, M.; Zapater, E.; Hostalet, F.; Basterra, J. 1996: Cholesterol granuloma of the middle ear: report of 5 cases. Acta Oto-Rhino-Laryngologica Belgica 50(2): 125-129
Loeffler, K.U.; Kommerell, G. 1997: Cholesterol granuloma of the orbit--pathogenesis and surgical management. International Ophthalmology 21(2): 93-98
Brodkey, J.A.; Robertson, J.H.; Shea, J.J.; Gardner, G. 1996: Cholesterol granulomas of the petrous apex: combined neurosurgical and otological management. Journal of Neurosurgery 85(4): 625-633
Shmeeda, H.; Petkova, D.; Barenholz, Y. 1994: Cholesterol homeostasis in cultures of rat heart myocytes: relationship to cellular hypertrophy. American Journal of Physiology 267(5 Pt 2): H1689-H1697
Lütjohann, D.; Breuer, O.; Ahlborg, G.; Nennesmo, I.; Sidén, A.; Diczfalusy, U.; Björkhem, I. 1996: Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proceedings of the National Academy of Sciences of the United States of America 93(18): 9799-9804
Björkhem, I.; Lütjohann, D.; Diczfalusy, U.; Ståhle, L.; Ahlborg, G.; Wahren, J. 1998: Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. Journal of Lipid Research 39(8): 1594-1600
Lange, Y.; Duan, H.; Mazzone, T. 1996: Cholesterol homeostasis is modulated by amphiphiles at transcriptional and post-transcriptional loci. Journal of Lipid Research 37(3): 534-539
Accad, M.; Farese, R.V. 1998: Cholesterol homeostasis: A role for oxysterols. Current Biology: Cb 8(17): R601-R604
Osborne, T.F. 1997: Cholesterol homeostasis: clipping out a slippery regulator. Current Biology: Cb 7(3): R172-R174
Lange, Y.; Steck, T.L. 1994: Cholesterol homeostasis. Modulation by amphiphiles. Journal of Biological Chemistry 269(47): 29371-29374
Worthman, L.A.; Nag, K.; Davis, P.J.; Keough, K.M. 1997: Cholesterol in condensed and fluid phosphatidylcholine monolayers studied by epifluorescence microscopy. Biophysical Journal 72(6): 2569-2580
Oehlenschlaeger, J. 1998: Cholesterol in crustaceans: Analysis and content. Schriftenreihe des Bundesministeriums fuer Ernaehrung Landwirtschaft und Forsten Reihe A Angewandte Wissenschaft 1998(469): 75-81
Warnick, G.R.; Leary, E.T.; Ammirati, E.B.; Allen, M.P. 1994: Cholesterol in fingerstick capillary specimens can be equivalent to conventional venous measurements. Archives of Pathology and Laboratory Medicine 118(11): 1110-1114
Edholm, O.; Nyberg, A.M. 1992: Cholesterol in model membranes. a molecular dynamics simulation. Biophysical Journal 63(4): 1081-1089
Valsa, J.; Skandhan, K.P.; Umarvanshi, V. 1992: Cholesterol in normal and pathological seminal plasma. Panminerva Medica 34(4): 160-162
Rubins, H.B. 1995: Cholesterol in patients with coronary heart disease: how low should we go?. Journal of General Internal Medicine 10(8): 464-471
Nakajima, K.; Saito, T.; Tamura, A.; Suzuki, M.; Nakano, T.; Adachi, M.; Tanaka, A.; Tada, N.; Nakamura, H.; Campos, E. 1993: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clinica Chimica Acta; International Journal of Clinical Chemistry 223(1-2): 53-71
Franklin, D.L.; Arana-Chavez, V.E.; Katchburian, E. 1994: Cholesterol in the distal portions of differentiating and fully differentiated rat odontoblasts observed by freeze-fracture. Archives of Oral Biology 39(9): 817-819
Tani, H.; Sato, M.; Tsuchiya, H.; Namikawa, I. 1993: Cholesterol incorporation into Bacillus megaterium without compositional modification of membrane lipids in response to changes of the membrane functions. Current Microbiology 26(5): 253-256
Echegoyen, S.; Oliva, E.B.; Sepulveda, J.; Díaz-Zagoya, J.C.; Espinosa-García, M.T.; Pardo, J.P.; Martínez, F. 1993: Cholesterol increase in mitochondria: its effect on inner-membrane functions, submitochondrial localization and ultrastructural morphology. Biochemical Journal 289: 703-708
Ortega, A.; Santiago-García, J.; Mas-Oliva, J.; Lepock, J.R. 1996: Cholesterol increases the thermal stability of the Ca2+/Mg(2+)-ATPase of cardiac microsomes. Biochimica Et Biophysica Acta 1283(1): 45-50
Kobayashi, K.; Igimi, H. 1995: Cholesterol index of hair in normal and hypercholesterolemic mice. Clinical Chemistry 41(12 Pt 1): 1775
Hexeberg, S.; Willumsen, N.; Rotevatn, S.; Hexeberg, E.; Berge, R.K. 1993: Cholesterol induced lipid accumulation in myocardial cells of rats. Cardiovascular Research 27(3): 442-446
Sanina, N.M.; Kostetskii, E.Y. 1995: Cholesterol influence on phase transitions of phosphatidylcholine obtained from holothuria Halocynthia aurantium. Zhurnal Evolyutsionnoi Biokhimii i Fiziologii 31(3): 366-369
Fanelli, S.L.; Castro, G.D.; Castro, J.A. 1995: Cholesterol interaction with free radicals produced from carbon tetrachloride or bromotrichloromethane by either catalytic decomposition or via liver microsomal activation. Chemico-Biological Interactions 98(3): 223-236
Colles, S.M.; Woodford, J.K.; Moncecchi, D.; Myers-Payne, S.C.; McLean, L.R.; Billheimer, J.T.; Schroeder, F. 1995: Cholesterol interaction with recombinant human sterol carrier protein-2. Lipids 30(9): 795-803
Slotte, J.P.; Ostman, A.L.; Kumar, E.R.; Bittman, R. 1993: Cholesterol interacts with lactosyl and maltosyl cerebrosides but not with glucosyl or galactosyl cerebrosides in mixed monolayers. Biochemistry 32(31): 7886-7892
Li, Q.; Komaba, A.; Yokoyama, S. 1993: Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry 32(17): 4597-4603
Keller, P.; Simons, K. 1998: Cholesterol is required for surface transport of influenza virus hemagglutinin. Journal of Cell Biology 140(6): 1357-1367
Tarshis, M.; Salman, M.; Rottem, S. 1993: Cholesterol is required for the fusion of single unilamellar vesicles with Mycoplasma capricolum. Biophysical Journal 64(3): 709-715
Schwartz, C.C.; Zech, L.A.; VandenBroek, J.M.; Cooper, P.S. 1993: Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate. Journal of Clinical Investigation 91(3): 923-938
Falkenberg, H.; Nuernberg, K.; Kuhn, G.; Nuernberg, G. 1995: Cholesterol level in blood and in fatty tissue and their relations to carcass and meat quality of pigs. Archiv fuer Tierzucht 38(6): 653-663
Crockett; Hazel 1995: Cholesterol levels explain inverse compensation of membrane order in brush border but not homeoviscous adaptation in basolateral membranes from the intestinal epithelia of rainbow trout. Journal of Experimental Biology 198(Pt 5): 1105-1113
Bottalico, L.A.; Keesler, G.A.; Fless, G.M.; Tabas, I. 1993: Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation. Journal of Biological Chemistry 268(12): 8569-8573
Strandberg, T.E.; Lehto, S.; Pyörälä, K.; Kesäniemi, A.; Oksa, H. 1997: Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland. European Heart Journal 18(11): 1725-1727
Smith, G.D.; Song, F.; Sheldon, T.A. 1993: Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 306(6889): 1367-1373
Pedersen, T.R.; Kjekshus, J.; Berg, K.; Olsson, A.G.; Wilhelmsen, L.; Wedel, H.; Pyörälä, K.; Miettinen, T.; Haghfelt, T.; Faergeman, O.; Thorgeirsson, G.; Jönsson, B.; Schwartz, J.S. 1996: Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation 93(10): 1796-1802
Eisenberg, D.A. 1998: Cholesterol lowering in the management of coronary artery disease: The clinical implications of recent trials. American Journal of Medicine 104(2a): 2s-5s
Megnien, J.L.; Simon, A.; Andriani, A.; Segond, P.; Jeannin, S.; Levenson, J. 1996: Cholesterol lowering therapy inhibits the low-flow mediated vasoconstriction of the brachial artery in hypercholesterolaemic subjects. British Journal of Clinical Pharmacology 42(2): 187-193
Hebert, P.R.; Gaziano, J.M.; Chan, K.S.; Hennekens, C.H. 1997: Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278(4): 313-321
Larosa, J.C. 1993: Cholesterol lowering, low cholesterol, and mortality. American Journal of Cardiology 72(11): 776-786
Vanhanen, H. 1994: Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients. European Journal of Clinical Pharmacology 47(2): 169-176
Van-Der-Weijden, T.; Hutten, J., B.F.; Brandenburg, B., J.; Grol, R., P.T.M.; Van-Der-Velden, K. 1994: Cholesterol management in Dutch general practice: A comparison with national guidelines. Scandinavian Journal of Primary Health Care 12(4): 281-288
Lapinleimu, H.; Viikari, J.; Jokinen, E.; Routi, T.; Salo, P.; Hollo, O.; Niinikoski, H.; Rönnemaa, T.; Leino, A.; Välimäki, I. 1994: Cholesterol measurement by reflotron dry chemistry in infants, children and adults. Scandinavian Journal of Clinical and Laboratory Investigation 54(1): 61-65
Patil, S.; Kanase, A. 1995: Cholesterol mediated changes in beta-glucuronidase activities of rat theca interstitial cells and granulosa cells. Indian Journal of Experimental Biology 33(5): 321-324
Kritharides, L.; Christian, A.; Stoudt, G.; Morel, D.; Rothblat, G.H. 1998: Cholesterol metabolism and efflux in human THP-1 macrophages. Arteriosclerosis Thrombosis and Vascular Biology 18(10): 1589-1599
Hakala, K.; Luukkonen, P.; Vuoristo, M.; Järvinen, H.; Miettinen, T.A. 1997: Cholesterol metabolism and non-cholesterol sterols in patients with ileal pouch anastomosis. Journal of Hepatology 26(6): 1306-1312
Miettinen, T.E.; Kiviluoto, T.; Taavitsainen, M.; Vuoristo, M.; Miettinen, T.A. 1998: Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Hepatology 27(3): 649-655
Gray, R.F.; Corrigan, F.M.; Strathdee, A.; Skinner, E.R.; van Rhijn, A.G.; Horrobin, D.F. 1993: Cholesterol metabolism and violence: a study of individuals convicted of violent crimes. Neuroreport 4(6): 754-756
Croll, D.H.; Ausman, L.M.; Nicolosi, R.J. 1993: Cholesterol metabolism in New World primates: Comparative studies in two tamarin species (Saguinus oedipus and Saguinus fuscicollis) and the squirrel monkey (Saimiri sciureus). Comparative Biochemistry and Physiology. B Comparative Biochemistry 106(4): 845-853
Oettl, K.; Malle, E.; Grillhofer, H.; Sattler, W.; Kostner, G.M. 1996: Cholesterol metabolism in cells with different peroxisomal defects. Clinica Chimica Acta; International Journal of Clinical Chemistry 251(2): 131-143
Wanner, C.; Krämer-Guth, A.; Nauck, M.; Quaschning, T.; Pavenstädt, H.; Schollmeyer, P. 1996: Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients. Mineral and Electrolyte Metabolism 22(1-3): 39-46
Ishii, I.; Kimuro, T.; Saito, Y.; Hirose, S. 1995: Cholesterol metabolism in monocyte-derived macrophages from macrophage colony-stimulating factor administered rabbits. Biochimica Et Biophysica Acta 1254(1): 51-55
Harvey, P.R.; Upadhya, G.A.; Strasberg, S.M. 1995: Cholesterol microcrystals associated with concanavalin A-binding glycoproteins contribute artifactually to nucleating activity assays. Journal of Lipid Research 36(12): 2661-2669
Porter, J.A.; Young, K.E.; Beachy, P.A. 1996: Cholesterol modification of hedgehog signaling proteins in animal development. Science 274(5285): 255-259
Parasassi, T.; Di Stefano, M.; Loiero, M.; Ravagnan, G.; Gratton, E. 1994: Cholesterol modifies water concentration and dynamics in phospholipid bilayers: A fluorescence study using laurdan probe. Biophysical Journal 66(3 Pt 1): 763-768
Bodovitz, S.; Klein, W.L. 1996: Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. Journal of Biological Chemistry 271(8): 4436-4440
Nabekura, T.; Takano, M.; Inui, K. 1996: Cholesterol modulates organic cation transport activity and lipid fluidity in rat renal brush-border membranes. Biochimica Et Biophysica Acta 1283(2): 232-236
Cornelius, F. 1995: Cholesterol modulation of molecular activity of reconstituted shark Na+,K(+)-ATPase. Biochimica Et Biophysica Acta 1235(2): 205-212
Lijnen, P.; Petrov, V. 1995: Cholesterol modulation of transmembrane cation transport systems in human erythrocytes. Biochemical and Molecular Medicine 56(1): 52-62
Ahrendt, S.A.; Fox-Talbot, K.; Kaufman, H.S.; Lillemoe, K.D.; Pitt, H.A. 1994: Cholesterol nucleates rapidly from mixed micelles in the prairie dog. Biochimica Et Biophysica Acta 1211(1): 7-13
Holzbach, R.T. 1995: Cholesterol nucleation in bile. Italian Journal of Gastroenterology 27(2): 101-105
Petroni, M.L.; Jazrawi, R.P.; Ahmed, H.A.; Finch, P.J.; Dormandy, J.; Northfield, T.C. 1993: Cholesterol nucleation time measurement in nasobiliary or nasoduodenal bile. Comparison with surgical bile. Scandinavian Journal of Gastroenterology 28(9): 803-808
Purcell, J.P.; Greenplate, J.T.; Jennings, M.G.; Ryerse, J.S.; Pershing, J.C.; Sims, S.R.; Prinsen, M.J.; Corbin, D.R.; Tran, M.; Sammons, R.D. 1993: Cholesterol oxidase: A potent insecticidal protein active against boll weevil larvae. Biochemical and Biophysical Research Communications 196(3): 1406-1413
Vasudevan, P.T.; Zhou, T. 1996: Cholesterol oxidation by microencapsulated cholesterol oxidase. Applied Biochemistry and Biotechnology 59(1): 1-6
Nielsen, J.H.; Olsen, C.E.; Skibsted, L.H. 1996: Cholesterol oxidation in a heterogeneous system initiated by water-soluble radicals. Food Chemistry 56(1): 33-37
Zunin, P.; Evangelisti, F.; Caboni, M.F.; Penazzi, G.; Lercker, G.; Tiscornia, E. 1995: Cholesterol oxidation in baked foods containing fresh and powdered eggs. Journal of Food Science 60(5): 913-916
Engeseth, N.J.; Ian Gray, J. 1994: Cholesterol oxidation in muscle tissue. Meat Science 36(3): 309-320
Chen, J.S.; Yen, G.C. 1994: Cholesterol oxidation products in small sun-dried fish. Food Chemistry 50(2): 167-170
Wood, W.G.; Igbavboa, U.; Rao, A.M.; Schroeder, F.; Avdulov, N.A. 1995: Cholesterol oxidation reduces Ca(2+)+MG (2+)-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes. Brain Research 683(1): 36-42
Girão, H.; Mota, M.C.; Ramalho, J.; Pereira, P. 1998: Cholesterol oxides accumulate in human cataracts. Experimental Eye Research 66(5): 645-652
Lebovics, V.K.; Gaal, O.; Somogyi, L.; Farkas, J. 1992: Cholesterol oxides in gamma-irradiated spray-dried egg powder. Journal of the Science of Food and Agriculture 60(2): 251-254
Mahfouz, M.M.; Zhou, Q.; Kummerow, F.A. 1994: Cholesterol oxides in plasma and lipoproteins of magnesium-deficient rabbits and effects of their lipoproteins on endothelial barrier function. Magnesium Research 7(3-4): 207-222
Chang, J.Y.; Chavis, J.A.; Liu, L.Z.; Drew, P.D. 1998: Cholesterol oxides induce programmed cell death in microglial cells. Biochemical and Biophysical Research Communications 249(3): 817-821
Pryor, W.A.; Wang, K.; Bermúdez, E. 1992: Cholesterol ozonation products as biomarkers for ozone exposure in rats. Biochemical and Biophysical Research Communications 188(2): 618-623
Fudim-Levin, E.; Bor, A.; Kaplun, A.; Talmon, Y.; Lichtenberg, D. 1995: Cholesterol precipitation from cholesterol-supersaturated bile models. Biochimica Et Biophysica Acta 1259(1): 23-28
Sutherland, W.H.; Walker, R.J.; Ball, M.J.; Stapley, S.A.; Corboy, J.; Robertson, M.C. 1995: Cholesterol precursor concentration in plasma from patients with chronic renal failure or kidney grafts. Clinical Nephrology 43(6): 392-398
Parasassi, T.; Giusti, A.M.; Raimondi, M.; Ravagnan, G.; Sapora, O.; Gratton, E. 1995: Cholesterol protects the phospholipid bilayer from oxidative damage. Free Radical Biology and Medicine 19(4): 511-516
Klansek, J.J.; Yancey, P.; St Clair, R.W.; Fischer, R.T.; Johnson, W.J.; Glick, J.M. 1995: Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. Journal of Lipid Research 36(10): 2261-2266
Boesze-Battaglia, K.; Clayton, S.T.; Schimmel, R.J. 1996: Cholesterol redistribution within human platelet plasma membrane: evidence for a stimulus-dependent event. Biochemistry 35(21): 6664-6673
Macmahon, S. 1994: Cholesterol reduction and death from non-coronary causes: evidence from randomised controlled trials. Australian and New Zealand Journal of Medicine 24(1): 120-123
Holme, I. 1995: Cholesterol reduction and its impact on coronary artery disease and total mortality. American Journal of Cardiology 76(9): 10c-17c
Smith, D.M.; Awad, A.C.; Bennink, M.R.; Gill, J.L. 1995: Cholesterol reduction in liquid egg yolk using beta-cyclodextrin. Journal of Food Science 60(4): 691-694, 720
Gould, A.L.; Rossouw, J.E.; Santanello, N.C.; Heyse, J.F.; Furberg, C.D. 1995: Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 91(8): 2274-2282
Gould, A.L.; Rossouw, J.E.; Santanello, N.C.; Heyse, J.F.; Furberg, C.D. 1998: Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 97(10): 946-952
Gaziano, J.M.; Hebert, P.R.; Hennekens, C.H. 1996: Cholesterol reduction: weighing the benefits and risks. Annals of Internal Medicine 124(10): 914-918
Esfahani, M.; Bigler, R.D.; Alfieri, J.L.; Lund-Katz, S.; Baum, J.D.; Scerbo, L. 1993: Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes. Biochimica Et Biophysica Acta 1149(2): 217-223
Yen, G.C.; Tsai, L.J. 1995: Cholesterol removal from a lard-water mixture with beta-cyclodextrin. Journal of Food Science 60(3): 561-564, 586
Goodrum, J.F.; Pentchev, P.G. 1997: Cholesterol reutilization during myelination of regenerating PNS axons is impaired in Niemann-Pick disease type C mice. Journal of Neuroscience Research 49(3): 389-392
Miquel, J.F.; Núñez, L.; Amigo, L.; González, S.; Raddatz, A.; Rigotti, A.; Nervi, F. 1998: Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile. Gastroenterology 114(5): 1016-1023
Nichol, K.L.; Azar, M.M.; Basara, M.L. 1993: Cholesterol screening for blood donors: characteristics of screenees and determinants of follow-up behavior. American Journal of Preventive Medicine 9(4): 231-236
Garber, A.M.; Browner, W.S.; Hulley, S.B. 1996: Cholesterol screening in asymptomatic adults, revisited. Part 2. Annals of Internal Medicine 124(5): 518-531
Garber, A.M. 1997: Cholesterol screening should be targeted. American Journal of Medicine 102(2a): 26-30
Dong, S.; Deng, Q.; Cheng, G. 1993: Cholesterol sensor based on electrodeposition of catalytic palladium particles. Analytica Chimica Acta 279(2): 235-240
Ahmad, S.; Roy, P.K.; Basu, S.K.; Johri, B.N. 1993: Cholesterol side-chain cleavage by immobilized cells of Rhodococcus equi DSM 89-133. Indian Journal of Experimental Biology 31(4): 319-322
Denning, M.F.; Kazanietz, M.G.; Blumberg, P.M.; Yuspa, S.H. 1995: Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 6(12): 1619-1626
Sato, J.; Denda, M.; Nakanishi, J.; Nomura, J.; Koyama, J. 1998: Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum. Journal of Investigative Dermatology 111(2): 189-193
Tempesta, M.C.; Salvayre, R.; Bonafé, J.L.; Levade, T. 1995: Cholesterol sulfate is not degraded but does not accumulate in Epstein-Barr virus-transformed lymphoid cells from patients with X-linked ichthyosis. Biochimica Et Biophysica Acta 1272(2): 80-88
Ikuta, T.; Chida, K.; Tajima, O.; Matsuura, Y.; Iwamori, M.; Ueda, Y.; Mizuno, K.; Ohno, S.; Kuroki, T. 1994: Cholesterol sulfate, a novel activator for the eta isoform of protein kinase C. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 5(9): 943-947
Chida, K.; Murakami, A.; Tagawa, T.; Ikuta, T.; Kuroki, T. 1995: Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis. Cancer Research 55(21): 4865-4869
Aksoy, I.A.; Otterness, D.M.; Weinshilboum, R.M. 1993: Cholesterol sulfation in human liver. Catalysis by dehydroepiandrosterone sulfotransferase. Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(2): 268-276
Avila, J.L.; Rojas, M.; Avila, A. 1996: Cholesterol sulphate-reactive autoantibodies are specifically increased in chronic chagasic human patients. Clinical and Experimental Immunology 103(1): 40-46
Nanji, A.A.; Rahemtulla, A.; Daly, T.; Khwaja, S.; Miao, L.; Zhao, S.; Tahan, S.R. 1997: Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the rat. Hepatology 26(1): 90-97
Iglesias, J.; Gonzalez-Pacanowska, D.; Marco, C.; Garcia-Peregrin, E. 1993: Cholesterol synthesis and esterification in isolated enterocytes: regulation by cholesterol and cholestyramine feeding. Lipids 28(6): 549-553
Poirier, J.; Baccichet, A.; Dea, D.; Gauthier, S. 1993: Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55(1): 81-90
Goodrum, J.F. 1993: Cholesterol synthesis in regenerating peripheral nerve is not influenced by serum cholesterol levels. Journal of Neurochemistry 60(4): 1564-1566
Pazzucconi, F.; Franceschini, G.; Gianfranceschi, G.; Campagnoli, G.; Sirtori, C.R. 1996: Cholesterol synthesis inhibitors do not reduce Lp(a) levels in normocholesterolemic patients. Pharmacological Research 34(3-4): 131-133
Smit, J.W.; VanErpecum, K.J.; VanBerge-Henegouwen, G.P. 1996: Cholesterol synthesis inhibitors in cholesterol gallstone disease. Scandinavian Journal of Gastroenterology. Supplement 218: 56-60
Kasiske, B.L.; O'Donnell, M.P.; Kim, Y.; Atluru, D.; Keane, W.F. 1994: Cholesterol synthesis inhibitors inhibit more than cholesterol synthesis. Kidney International. Supplement 45: S51-S53
Smith, B.H.; Vranjkovic, V.; McEwan, S.R.; Ritchie, L.D. 1996: Cholesterol testing by general practitioners in Grampian: patterns and outcomes. Scottish Medical Journal 41(3): 78-82
Stevens, V.L.; Xu, T.; Lambeth, J.D. 1993: Cholesterol trafficking in steroidogenic cells. Reversible cycloheximide-dependent accumulation of cholesterol in a pre-steroidogenic pool. European Journal of Biochemistry 216(2): 557-563
Bottum, K.; Jonas, A. 1995: Cholesterol transfer from low density lipoproteins to reconstituted high density lipoproteins is determined by the properties and concentrations of both particles. Biochemistry 34(21): 7264-7270
Lopez-Candales, A.; Bosner, M., S.; Spilburg, C., A.; Lange, L., G. 1993: Cholesterol transport function of pancreatic cholesterol esterase: Directed sterol uptake esterification in enterocytes. Biochemistry 32(45): 12085-12089
Miller, S.; Wehner, J.M. 1994: Cholesterol treatment facilitates spatial learning performance in DBA/2Ibg mice. Pharmacology Biochemistry and Behavior 49(1): 257-261
Reaven, E.; Tsai, L.; Azhar, S. 1995: Cholesterol uptake by the 'selective' pathway of ovarian granulosa cells: early intracellular events. Journal of Lipid Research 36(7): 1602-1617
Safonova, I.G.; Sviridov, D.D.; Roytman, A.; Rytikov, F.M.; Dolgov, V.V.; Nano, J.L.; Rampal, P.; Repin, V.S. 1993: Cholesterol uptake in the human intestine. Hypo- and hyperresponsiveness. Biochimica et Biophysica Acta 1166(2-3): 313-316
Stillwell, W.; Dallman, T.; Dumaual, A.C.; Crump, F.T.; Jenski, L.J. 1996: Cholesterol versus alpha-tocopherol: effects on properties of bilayers made from heteroacid phosphatidylcholines. Biochemistry 35(41): 13353-13362
Caselli, M.; Aleotti, A.; Navarra, G.; Carcoforo, P.; Cervellati, F.; Alvisi, V. 1996: Cholesterol vesicles in areas of gastric metaplasia of gallbladder epithelium. Journal of Submicroscopic Cytology and Pathology 28(2): 251-253
Ali, S.; Smaby, J.M.; Brockman, H.L.; Brown, R.E. 1994: Cholesterol's interfacial interactions with galactosylceramides. Biochemistry 33(10): 2900-2906
Smaby, J.M.; Brockman, H.L.; Brown, R.E. 1994: Cholesterol's interfacial interactions with sphingomyelins and phosphatidylcholines: hydrocarbon chain structure determines the magnitude of condensation. Biochemistry 33(31): 9135-9142
Maccarrone, M.; Bellincampi, L.; Melino, G.; Finazzi Agrò, A. 1998: Cholesterol, but not its esters, triggers programmed cell death in human erythroleukemia K562 cells. European Journal of Biochemistry 253(1): 107-113
Tulenko, T., N.; Laury-Kleintop, L.; Walter, M., F.; Mason, R.P.eston 1997: Cholesterol, calcium and atherosclerosis: Is there a role for calcium channel blockers in atheroprotection?. International Journal of Cardiology 62(Suppl 2): S55-S66
Prospective-Studies-Collaboration 1995: Cholesterol, diastolic blood pressure, and stroke: 13000 strokes in 450000 people in 45 prospective cohorts. Lancet (North American Edition) 346(8991): 1647-1653
Duindam, J.J.; Vrensen, G.F.; Otto, C.; Greve, J. 1998: Cholesterol, phospholipid, and protein changes in focal opacities in the human eye lens. IOVS Investigative Ophthalmology and Visual Science 39(1): 94-103
Grizard, G.; Sion, B.; Jouanel, P.; Benoit, P.; Boucher, D. 1995: Cholesterol, phospholipids and markers of the function of the accessory sex glands in the semen of men with hypercholesterolaemia. International Journal of Andrology 18(3): 151-156
Carrier, M.; Pelletier, G.B.; Genest, J.; Cartier, R.; Leclerc, Y.; Pelletier, L.C. 1994: Cholesterol-Lowering Intervention and Coronary Artery Disease After Cardiac Transplantation. Annals of Thoracic Surgery 57(2): 353-356
Pohlentz, G.; Mokros, A.; Egge, H. 1996: Cholesterol-containing lactose derived neoglycolipids serve as acceptors for sialyltransferases from rat liver Golgi vesicles. Glycoconjugate Journal 13(2): 147-152
Kruse, R.; Merten, M.; Yoshida, K.; Schmidt, A.; Völker, W.; Buddecke, E. 1996: Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta. Basic Research in Cardiology 91(5): 344-352
Mizuno, T.; Haass, C.; Michikawa, M.; Yanagisawa, K. 1998: Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells. Biochimica et Biophysica Acta 1373(1): 119-130
Mayor, S.; Sabharanjak, S.; Maxfield, F.R. 1998: Cholesterol-dependent retention of GPI-anchored proteins in endosomes. EMBO Journal 17(16): 4626-4638
Marquardt, M.T.; Kielian, M. 1996: Cholesterol-depleted cells that are relatively permissive for Semliki Forest virus infection. Virology 224(1): 198-205
Daley, S.J.; Herderick, E.E.; Cornhill, J.F.; Rogers, K.A. 1994: Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 1: Differing lesion area and volume despite equal plasma cholesterol levels. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 14(1): 95-104
Daley, S.J.; Klemp, K.F.; Guyton, J.R.; Rogers, K.A. 1994: Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2: Differing morphological severity of atherogenesis despite matched plasma cholesterol levels. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 14(1): 105-141
Alfaro, M.J.; Ormazábal, M.J.; García-Arroba, L.; Martín, M.I. 1996: Cholesterol-fed rabbits: study of the response of the vas deferens to adrenergic and non-adrenergic stimulus and to a kappa-opioid agonist. Journal of Pharmacy and Pharmacology 48(4): 433-436
Hu, M.; Konoki, K.; Tachibana, K. 1996: Cholesterol-independent membrane disruption caused by triterpenoid saponins. Biochimica Et Biophysica Acta 1299(2): 252-258
Rolls, M.M.; Marquardt, M.T.; Kielian, M.; Machamer, C.E. 1997: Cholesterol-independent targeting of Golgi membrane proteins in insect cells. Molecular Biology of the Cell 8(11): 2111-2118
Smaby, J.M.; Momsen, M.; Kulkarni, V.S.; Brown, R.E. 1996: Cholesterol-induced interfacial area condensations of galactosylceramides and sphingomyelins with identical acyl chains. Biochemistry 35(18): 5696-5704
Pincelli, M., M.; Levstein, P., R.; Martin, C., A.; Fidelio, G., D. 1998: Cholesterol-induced stabilization of lamellar structures in ganglioside-containing lipid aggregates. A 31P-NMR study. Chemistry and Physics of Lipids 94(1): 109-118
Halstenberg, S.; Heimburg, T.; Hianik, T.; Kaatze, U.; Krivanek, R. 1998: Cholesterol-induced variations in the volume and enthalpy fluctuations of lipid bilayers. Biophysical Journal 75(1): 264-271
Allen, D.W.; Manning, N. 1996: Cholesterol-loading of membranes of normal erythrocytes inhibits phospholipid repair and arachidonoyl-CoA:1-palmitoyl-sn-glycero-3-phosphocholine acyl transferase. A model of spur cell anemia. Blood 87(8): 3489-3493
Yamaguchi, H.; Kawano, M.; Sugawa Katayama, Y.; Kususa, K. 1997: Cholesterol-lowering activity of linear-and gel-type sodium polyacrylate as dietary fiber models. Journal of Nutritional Biochemistry 8(6): 351-354
Denke, M.A. 1995: Cholesterol-lowering diets. a review of the evidence. Archives of Internal Medicine 155(1): 17-26
Feher, M.D.; Webb, J.C.; Patel, D.D.; Lant, A.F.; Mayne, P.D.; Knight, B.L.; Soutar, A.K. 1993: Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia. Atherosclerosis 103(2): 171-180
Shimokawa, T.; Goto, S.; Ugawa, T.; Hisamichi, N.; Naganuma, S.; IIzumi, Y.; Sato, N.; Takenaka, T.; Kodama, T. 1996: Cholesterol-lowering effect of YM-16638 in cynomolgus monkeys. Drug Development Research 38(2): 86-92
Matsuo, M.; Aketa, M.; Ozaki, R.; Tomoi, M.; Shimomura, K. 1995: Cholesterol-lowering effect of an acyl-coenzyme A:cholesterol acyltransferase inhibitor, FR145237, in hypercholesterolemic rabbits fed a high-cholesterol diet and a cholesterol-free casein diet. Drug Development Research 36(4): 186-192
Poupon, R.E.; Ouguerram, K.; Chrétien, Y.; Verneau, C.; Eschwège, E.; Magot, T.; Poupon, R. 1993: Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. Hepatology 17(4): 577-582
Kahlon, T.S.; Chow, F.I.; Knuckles, B.E.; Chiu, M.M. 1993: Cholesterol-lowering effects in hamsters of beta-glucan enriched barley fraction, dehulled whole barley, rice bran, and oat bran and their combinations. Cereal Chemistry 70(4): 435-440
Arruzazabala, M.L.; Carbajal, D.; Mas, R.; Molina, V.; Valdes, S.; Laguna, A. 1994: Cholesterol-lowering effects of policosanol in rabbits. Biological Research 27(3-4): 205-208
Pflugfelder, P.W.; Huff, M.; Oskalns, R.; Rudas, L.; Kostuk, W.J. 1995: Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 14(4): 613-622
Lam, K.S.; Cheng, I.K.; Janus, E.D.; Pang, R.W. 1995: Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38(5): 604-609
Oster, G.; Borok, G.M.; Menzin, J.; Heyse, J.F.; Epstein, R.S.; Quinn, V.; Benson, V.; Dudl, R.J.; Epstein, A.M. 1996: Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practice. Archives of Internal Medicine 156(7): 731-739
Hyman, D.J.; Clark, M.; Houston-Miller, N.; Johannsson, M.; Ghandour, G.; Shah, R.; Debusk, R.F. 1992: Cholesterol-related counseling by registered dietitians in northern California. Preventive Medicine 21(6): 746-753
Hyman, D.J.; Simons-Morton, D.G.; Ho, K.; Dunn, J.K.; Rubovits, D.S. 1993: Cholesterol-related knowledge, attitudes, and behaviors in a low-income, urban patient population. American Journal of Preventive Medicine 9(5): 282-289
Oda, H.; Matsushita, N.; Hirabayashi, A.; Yoshida, A. 1994: Cholesterol-rich very low density lipoproteins and fatty liver in rats fed polychlorinated biphenyls. Bioscience Biotechnology and Biochemistry 58(12): 2152-2158
Harris; Adrian; Bhakdi; Palmer 1998: Cholesterol-Streptolysin O Interaction: An EM Study of Wild-Type and Mutant Streptolysin O. Journal of Structural Biology 121(3): 343-355
Joseph, J.A.; Villalobos-Molinas, R.; Denisova, N.A.; Erat, S.; Strain, J. 1997: Cholesterol: A two-edged sword in brain aging. Free Radical Biology and Medicine 22(3): 455-462